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  Abstract 
Neuropsychiatric disorders alter neural activity in those who suffer from these diseases. 
High-throughput screening can be used to find drugs with fewer debilitating side effects than 
current treatments. C. elegans nematodes are ideal models for high-throughput testing and for 
observing neural activity in intact neural circuits, but current screening experiments using C. 
elegans are conducted manually, which is time-consuming and hands-on for the researcher. 
Automated screening systems save time and effort, but are expensive and cannot be tailored to fit 
the specific needs of neural imaging in C. elegans. We designed an automated, modular, and 
inexpensive system for use in chemical screening with C. elegans. This improved chemical 
delivery system used off-the-shelf robotic hardware, a 3D-printed microplate tray, and open-
source electronics and control software, costing ~$300. Our method sequentially delivers test 
chemicals from a 96-well microplate, with low cross-contamination (<0.01%) and satisfactory 
switching speed (<1 min) between chemicals. We validated our system by reproducing the dose-
response results published in a previous C. elegans chemical screening experiment.  
Keywords―C. elegans, automation, high-throughput screening, neural imaging 
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 Chapter 1: Introduction 
The brain is the least understood organ in the human body. Responsible for a wide variety 
of functions, the brain allows us to think, remember, perceive, control movements, and interact 
with one another. Approximately 86 billion neurons, or nervous system cells, communicate to 
relay and process information throughout the body via electrical and chemical signals (Azevedo 
et al. 2009). The health of these cells and their connections is imperative to the execution of 
neurological functions. Unfortunately, neurological disorders can hinder these processes due to 
malfunctions in the nervous system, causing decreased functionality in behavior and cognition. 
In diseases like schizophrenia and autism, the complex factors that cause these functional deficits 
are relatively unknown. 
 Schizophrenia and autism are two prevalent neuropsychiatric disorders that adversely 
affect patients' quality of life. While these conditions can be managed with medicinal and 
psychiatric interventions, neither of them is curable. Furthermore, the drugs that are used to 
alleviate symptoms, most commonly antipsychotic drugs, often result in adverse side effects, one 
of which is the increased risk of venous thromboembolism (Parker et al. 2010). Due to the 
immense complexity of mammalian neural systems, these disorders are difficult to study in such 
models, especially in human beings. For this reason, as well as many others, Caenorhabditis 
elegans (C. elegans) is a promising model system for in vivo neuropsychiatric disorder research 
and drug discovery. 
Researchers have explored various animal models to test novel neurotherapeutics with 
the end-goal of finding a treatment for neurological diseases. Conducting experiments using 
mammalian models, such as rodents, is marked by challenges. In a neuroprotective therapy 
study, approximately 500 drugs were tested on rodent models, but only one of these drugs passed 
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 clinical trials and became an approved therapy (Chesselet, 2012). This example emphasizes the 
degree of throughput needed to adequately screen for drug options. Additionally, due to the large 
library of drugs that remain to be tested for the treatment of neurological diseases, mammalian 
systems are not practical models. Microscopic nematodes are a viable alternative, providing a 
number of benefits, one being their capacity for high-throughput applications. C. elegans, which 
are microscopic, transparent roundworms (approximately 1 mm long), are an ideal animal model 
for a number of reasons. They are easy to maintain, since they require a simple environment 
(agar filled petri dish) and food source (E. coli) for growth, and they reach maturity in three days, 
allowing for convenient experiment staging. The nematode’s transparent body provides a clear 
visualization of internal structures and processes.  C. elegans contain exactly 959 cells, 302 of 
which are neurons and 95 of which are body wall muscles. C. elegans was the first animal to 
have its genome fully sequenced, with further studies resulting in the complete mapping of its 
neural network (Sleigh, 2010). C. elegans genes are also 50 percent homologous to human genes, 
and their proteomes are 83 percent homologous to those of humans, making them suitable 
models for neuropsychiatric disease research (Caldwell, 2008; Lai et al, 2000). Scientists can 
manipulate and mutate C. elegans to match the same diseased genes that would be present in 
human patients, thus increasing their utility as neuropsychiatric models. Testing many different 
therapies for neurological diseases on mutated worms, high-throughput chemical screening 
involves sequentially introducing chemicals or chemical cocktails to a microfluidic arena where 
the C. elegans reside. Upon exposure to the stimuli, the worms typically respond, and these 
responses can be quantified behaviorally and neurologically using computer software 
(MATLAB, ImageJ, etc.) (Larsch, et al, 2013). These tests can be used to refine the candidate 
11 
 
 pool for successful drug therapies, which can then be scaled for mammalian studies, with the 
ultimate goal of reaching clinical trials in humans. 
Currently, two methods exist for chemical screening applications using C. elegans. One 
of these methods is manual screening, which involves sequentially flowing different chemicals 
from a 96-well plate through a microfluidic arena containing C. elegans. The activity of these 
worms is either recorded on a behavioral level, using bright-field microscopy video recordings, 
or on a neurological level by imaging fluorescently labeled neurons. This is an effective method 
of microfluidic liquid delivery because it is relatively inexpensive (beyond the cost of the 
microscope, camera, and computer system), easy to conduct and troubleshoot, and adaptable 
(Giacomotto et al, 2012). However, because this method is conducted manually, it is susceptible 
to human error. This produces unrefined results, such as air bubbles and incorrect timing of 
chemical and liquid switching. By introducing air bubbles into the arena, the worms are not 
homogeneously exposed to the liquid, which can prevent them from coming in contact with the 
stimuli, ultimately altering the results. Similarly, because chemical screening is a systematic, 
time-dependent process, inserting the liquid into the arena too quickly or too slowly can affect 
the data collected and corrupt the results. Moreover, the experimenter has to be present for the 
entirety of the experiment, which poses problems with efficiency. 
The other method of chemical screening, automation, can be accomplished through three 
combined major functions: pipetting, liquid delivery, and sorting. The Gilson PIPETMAX can 
transfer a tray of 96 pipet tips concurrently from one 96-well plate to another, thus only serving 
the purpose of mass-pipetting (Pipetmax). The BioTek MicroFlo is a fluid dispensing system that 
can be used to transport C. elegans, as the nematodes can be mixed into a liquid medium, but this 
only transfers C. elegans from the library to the microfluidic arena by means of liquid delivery 
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 and does not address pipetting or sorting (Greene, 2007). The COPAS BIOSORT is a sorting 
machine that uses calcium imaging to read the degree of fluorescence emitted from test subjects. 
However, this imaging can only occur after the reagent has already been added and not during 
the uptake process, which limits its use in same-time automated monitoring (Copas). All of these 
devices are very expensive, on the order of at least tens of thousands of U.S. dollars, and each 
only executes one specific task. There is no standalone-automated system that carries out all 
three tasks of automation by itself, thus there is a need to create a system that can perform these 
functions, while dynamically monitoring neural activity in C. elegans. 
We plan to create an automated system to improve the throughput of the chemical 
screening of C. elegans by alleviating the current drawbacks associated with these methods. Our 
system will use inexpensive, polydimethylsiloxane (PDMS) cast microfluidic arenas that are 
capable of holding many nematodes at once. We aim to combine the dynamic capabilities of 
manual screening with the precision and ease-of-use associated with more expensive, automated 
chemical screening devices. Our formal client statement is to design, develop, and assess an 
automated system to improve the throughput of neurological screening assays in C. elegans by 
sequentially delivering chemicals from a 96-well plate to a microfluidic arena. After developing 
the system, we will test it to ensure that all of the functional constraints are met. These include 
the prevention of air bubble entry, contamination, and incorrect timing of chemical switches. If 
the device falls short of meeting any of these requirements, we will revise the design 
accordingly. Once we have a working system, we will use it to conduct chemical screening 
experiments using the C. elegans nematodes. 
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 Chapter 2: Literature Review 
Here we present a thorough synthesis of relevant information collected in our research of 
neuroscience, C. elegans, and chemical screening. Specifically, we emphasize human 
neuropsychiatric disorders, their effects on the brain, and the implications of research in the field. 
We then discuss C. elegans and the nature of research conducted with these nematodes. We 
conclude by explaining a specific venue of neuropsychiatric disorder research, using chemical 
screening, and C. elegans as disease model experiments to facilitate drug discovery. 
 
2.1 Neuroscience 
In this section, we explain the general physiology of the brain, focusing on human neural 
anatomy and neurotransmitters. We then explain how irregularities in neurotransmitter systems 
can lead to neuropsychiatric disorders, chiefly schizophrenia and autism spectrum disorders. We 
subsequently transition from the effects these disorders have on sufferers to current treatment 
methods, as well as what current research is being done for the advancement of neuropsychiatric 
disease treatment. 
2.1.1 Neurobiology 
This section serves as a general introduction to the field of neurobiology. Emphasis is placed on 
human neural anatomy and processes. 
The brain is the least understood organ of the human body, due to the complexity of both 
its anatomy and function. The brain is comprised of approximately 86 billion neurons, or nervous 
system cells, which communicate with one another through electrical and chemical signals 
(Azevedo et al., 2009). Neurons vary in function, chemical activity, and shape, but they generally 
contain the same fundamental cellular components. As shown in Figure 1 below, neurons 
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 comprise a primary cell body (soma), axons, and dendritic projections. The cell body contains a 
nucleus and maintains the fundamental cellular functions required for the life of the cell (Squire, 
2008). 
 
Figure 1: Neuron anatomy and physiology 
(http://www.helcohi.com/sse/body/nervous.html) 
 
There are three different classes of neurons in the body: sensory, motor, and interneurons 
(Bear et al., 2007). Sensory neurons are responsible for sensing things in the body’s 
environment, and are also referred to as afferent neurons because they relay information inward, 
to the central nervous system (CNS). Motor neurons are required for the execution of actions, 
which can manifest as things like physical movement or secretion from glands (Bear et al., 
2007). Motor neurons are also referred to as efferent, because they communicate information 
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 away from the CNS. Interneurons bridge the gap between sensory and motor neurons, allowing 
them to interface with one another (Bear et al., 2007).  
Neurons communicate with one another by sending electro-chemical signals via synapses 
and gap junctions (Bear et al., 2007). Chemical synapses are much more common in the CNS 
and have the ability to induce both excitatory and inhibitory responses. This form of neural 
communication is caused by the propagation of action potentials, which originate at the axon 
hillock (where the soma and axon meet) and travel through the axon to other neurons (Bear et al., 
2007). This cascade of events results from the exchange of ions (sodium (Na+), potassium (K+), 
calcium (Ca2+), and chlorine (Cl-)) into and out of neurons through transmitter-gated (t-gated) 
and voltage-gated (v-gated) ion channels, which ultimately enables the release of 
neurotransmitters.  
Neurotransmitters are signaling molecules that are synthesized in the cell body or axon 
terminal, packaged into synaptic vesicles, carried down the axon along microtubules (only the 
peptide molecules that are synthesized in the cell body), and released across the synapses present 
at the terminal end of each axon (the synaptic button, or axon tip as labeled in Figure 1) (Bear et 
al., 2007). Figure 2 below, illustrates the synaptic connection between two neurons, and the 
release of neurotransmitters across the synaptic cleft to interact with receptors on the 
postsynaptic neuron. 
16 
 
  
Figure 2: Release of neurotransmitter molecules across synapse (Bear et al., 2007) 
 
 There are two major classes of neurotransmitters: small molecule neurotransmitters and 
peptide neurotransmitters (Bear et al., 2007). The former class is divided into a number of 
different sub-categories that include: Acetylcholine, amino acids (e.g. glutamate, γ-aminobutyric 
acid (GABA), glycine), purines (e.g. ATP), and biogenic amines (e.g. dopamine, norepinephrine, 
and serotonin (5-HT). (Purves, Augustine, Fitzpatrick et al., 2001). These signaling molecules 
play important roles in a number of different neurological functions. The communication of 
neurons ultimately enables the body to sense internal and external environmental cues, and relays 
information to the brain and muscular system to allow for executed responses. Proper 
neurological activity is required for thinking, remembering, perceiving, controlling movements, 
and social interactions. 
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 2.1.2 Neuropsychiatric Disorders 
Abnormalities in the activation of voltage-gated ion channels in the central nervous system can 
directly cause abnormalities in “neurotransmitter release, neuron excitability, gene 
transcription, and plasticity.” Specifically, “point mutations in calcium, sodium, and potassium 
channel genes” are highly associated with certain neuropsychiatric disorders, such as bipolar 
disorder, schizophrenia, and autism (Hyman, 2010).  
Schizophrenia 
Schizophrenia in particular is caused by definitive neurobiological abnormalities. More 
explicitly, the cerebral cortex deteriorates, “most severely in prefrontal and temporal regions.” 
This thinning of the cerebral cortex is due to a decrease in dendritic branching in cortical 
neurons, and not because of cell death, as commonly believed. Additionally, cortical 
interneurons produce less GABA than necessary, thus establishing a major deficit of the brain’s 
primary inhibitory neurotransmitter. Finally, hormonal and neurotransmitter imbalances in the 
midbrain neurons significantly contribute to schizophrenia, by means of “excessive dopamine 
release in ventral and perhaps dorsal striatal projections of midbrain dopamine neurons” 
(Hyman, 2010). This results in increased excitability of the midbrain neurons and thus alters 
motor control and hormone release as well. 
To accurately gauge the importance of schizophrenia research, the worldwide lifetime 
prevalence, also known as the number of surviving individuals with the disease at any given 
point in time, must be clear. Although there is much variation between different geographic 
regions, social status, and sexes, McGrath et al. estimated the median lifetime prevalence of 
schizophrenia in all persons to be four per one thousand people, or about 0.4 percent of the 
population. Data from 46 countries were amassed, and an estimated 154,410 cases were 
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 consolidated, ultimately yielding this comprehensive estimate of worldwide prevalence 
(McGrath et al., 2008). 
Autism 
As autism is a spectrum disorder, symptoms range from mild to severe, depending on 
which form of the disease the sufferer has. Kanner syndrome is a form of autism that manifests 
as mental retardation. This can cause frustration in sufferers, which can then become aggression. 
On the other side of the spectrum, Asperger syndrome is a form of autism in which sufferers 
generally have higher levels of intelligence than normal. Their motor skills tend to be 
uncoordinated, but most have exceptional musical ability and rote memory. Additionally, a 
defining factor in Asperger syndrome is an obsession with routine (Autism main symptoms, 
2007). Comprehensively, autism causes behavioral and social hindrances, which manifest in 
difficulty communicating and uncomfortable social interactions (NINDS, 2009). 
Autism, like schizophrenia, is primarily caused by abnormalities in neurotransmitter 
systems. Variations in ion channel genes cause abnormal levels of serotonin and similar 
neurotransmitters in the brain, which then alters the excitability of the neurons. This can be 
attributed to abnormal brain growth during fetal development of autistic persons (NINDS, 2009). 
Early brain overgrowth then would result in increased neuron numbers in the prefrontal cortexes 
of young children with autism. Additionally, the characteristic imbalances in neurotransmitters 
are coupled with irregularities in the immune system. This then leads to neuroinflammation, 
which is common in persons with autism (Lai, 2014). 
Calahorro et al. estimate that roughly one percent of people have autism, but the rate of 
autism is rising, due to the fact that it is increasingly being recognized as a spectral disorder 
(Calahorro, 2011). Yeargin-Allsopp et al. reported the prevalence of autism spectrum disorders 
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 in young children ages three to ten, in metropolitan Atlanta, which was 34 per 10,000 
(Fombonne, 2003). 
2.1.3 Drug Research  
This section notes the current approaches being taken to treat these diseases in humans and the 
limitations that accompany them. This sets the stage for the clinical need for high-throughput 
drug discovery. 
Schizophrenia and autism differ in that schizophrenia is a psychotic disorder, while 
autistic spectrum disorders are pervasive developmental disorders (PDD’s) (Odle, et al., 2011). 
Psychotic disorders are widely treated with antipsychotic drugs, while PDD’s can be treated with 
general psychotropics, e.g. “antidepressants, stimulants, antipsychotics, or anti-epileptics.” 
Approximately half of patients suffering from PDD’s are prescribed one or more of these 
medications (Santosh et al., 2001). Leucht et al. conducted a study testing the efficacy of 
antipsychotics against placebo, and the results distinctly indicated that treatments with 
antipsychotics have much lower relative risks than placebo, at 27 versus 64 percent (Leucht et 
al., 2012). 
Although their efficacy has been widely tested and accepted as higher than that of 
placebo, antipsychotics have a number of side effects, namely weight gain and extrapyramidal 
side effects (Leucht et al., 2013). Extrapyramidal side effects are commonly involuntary muscle 
movement irregularities, such as dystonia, rigidity, hypokinesia/akinesia, dyskinesia, akathisia, 
and tremors/parasthesias. In layman’s terms, these are the erratic increase in muscle movement 
and the dramatic decrease in muscle movement speed (Houltram, 2004). 
These side effects, while coupled with efficacious treatments, are quite severe and barely 
manageable. If a treatment can be developed without causing such drastic side effects, the use of 
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 such a drug would be relatively widespread. Thus, there is a need to research drug alternatives 
and test whether the efficacy can be improved and side effects can be minimized. 
 
2.2 C. elegans 
This section provides an introduction to C. elegans history, anatomy, genetics, and 
research applications. Additionally, their use as a model system for neurological studies is 
discussed. 
2.2.1 History of C. elegans Research  
This section serves as an introduction to C. elegans research, providing the reader with a 
fundamental understanding of how long this field has been in existence, and how it has evolved 
over the past 50 years. 
Early research 
C. elegans are roundworm nematodes that are naturally found in soil or decaying plant 
matter (Felix, 2010). Dr. Sydney Brenner began C. elegans laboratory research in 1963. He 
sought to use C. elegans as a model organism for biology and neurology research due to their 
rapid life cycle, simple reproductive cycle, compact genome, and microscopic size (Ankeny, 
2001). Brenner used ethyl methanesulphonate (EMS) to mutate the C. elegans in order to test 
their behavioral response and survival rates. Experiments with EMS allowed Brenner to 
characterize 100 genes that were further mapped into six linkage groups (Ankeny, 2001). 
Brenner’s preliminary research prompted further C. elegans experimentation, making it the first 
animal to have its entire neural network mapped, thus allowing them to be applicable in various 
types of genetic and neurological drug testing. 
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 The earliest drugs testing techniques with C. elegans consumed large amounts of time 
and were labor and resource intensive. It was not until 2006 that C. elegans were used for a large 
scale high-throughput drug screen by Dr. Kwok and his colleagues to assess bio-activity of 
various compounds (Riley et al., 2014). As research progressed and methods for high-throughput 
experimentation were refined, scientists began utilizing C. elegans for drug discovery for 
neurological disorders due to their anatomy and simple genetic makeup (Ankeny, 2001). 
2.2.2 C. elegans Anatomy 
This section provides an anatomical overview of C. elegans, important for framing their 
usefulness in neurological research.   
General anatomy 
C. elegans nematodes are an ideal animal model for high-throughput biological research 
applications due to their size, life cycle, ease of reproduction, and anatomical and genetic 
simplicity. C. elegans are transparent, one-millimeter long worms that allow for easy laboratory 
maintenance. They can grow on agar plates or in liquid cultures with E. coli as a food source 
(Wood, 1987). Additionally, they mature to young adulthood in three days and live for 
approximately two to three weeks, given that they are under optimal temperature (20°C) and 
supplied with a sufficient amount of E. coli (Bono, 2005). Once they become young adults, C. 
elegans are able to reproduce, both sexually and asexually. Figure 3 below displays the C. 
elegans life cycle progressing from an egg to an adult. There is a point in the maturation cycle, 
after the middle of the first larval stage, where the C. elegans can enter an arrested development 
state called dauer, or the non-aging state. This is caused by two environmental factors – high 
temperature and lack of food (Riddle, 1988). C. elegans can survive up to four months during 
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 this state of starvation and minimal mobility. The four-month dauer larva can be stored and 
utilized for future experimentation (Wormatlas, 2006). 
 
Figure 3: C. elegans life cycle with given durations during development 
 
There are two C. elegans sexes, hermaphrodite (XX) and male (XO), as shown in Figure 
4. Hermaphrodite C. elegans can self-fertilize, which allows them to produce genetically 
identical offspring as well as males. Hermaphrodite self-fertilization can produce 300-350 
offspring, which is significantly greater during male fertilization (Wood, 1987). Furthermore, 
male mating simplifies the isolation and maintenance of mutated strains in the C. elegans 
(Anderson, 1995). The number of cells that make up C. elegans also depends on the gender; 
hermaphrodites contain 959 cells, while males contain 1031 (White, 1988). These cells comprise 
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 the hypodermis, muscles, digestive tract, reproductive system and nervous system (Figure 4). 
The C. elegans transparent body also provides researchers with a visualization of the nematode’s 
internal organs.  
 
 
Figure 4: C. elegans genders, hermaphrodite and male, with respective anatomical structures 
(Wormbook.org) 
Neural anatomy 
In 1998, C. elegans became the first multicellular organism with a completely sequenced 
genome, comprised of 302 or 381 genomes, in hermaphrodites and males respectively. This 
breakthrough induced further research of C. elegans to enhance the biological understanding of 
all animals (Hope, 1999). The hermaphrodite’s neurons can be grouped into 118 classes: 39 of 
which are sensory neurons, 27 motor neurons, and the remainder interneurons (Bono, 2005; 
White, 1988). The male C. elegans has 79 extra neurons (381 total), which are devoted to the 
male mating behavior (White, 1988). The neurons are predominantly located in the head around 
the pharynx of the C. elegans, as shown in Figure 5. In the body, there is also a continuous row 
of neurons at the midline and some scattered at the lateral parts of the body (Wormatlas, 2006).  
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Figure 5: C. elegans neural network with each neuron location within the body. 
(http://www.neuroinformatics2012.org/abstracts/the-neuroml-c.-elegans-connectome) 
 
C. elegans with 302 neurons have approximately 5000 chemical synapses, 600 gap 
junctions, and 200 neuromuscular junctions (Bono, 2005; White, 1988). Additionally, common 
neurotransmitters have been assigned to C. elegans neurons. These neurotransmitters include 
acetylcholine, glutamate, γ -aminobutyric acid (GABA), serotonin, and dopamine (Bono, 2005). 
The synapse and neurotransmitter can determine the excitability and inhibitory response of C. 
elegans. The neural response can be studied when C. elegans undergo various stimuli (Riley et 
al., 2014). 
2.2.3 Genetics 
This section serves as an introduction to C. elegans genetics, illustrating how they can be used 
as models for human disease genes. This has significant research implications, in that C. elegans 
can open the door to rapid means of clinical research, and they provide a less complicated 
methodology than working with larger, more complex animals. 
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 General Genetics 
The genome of C. elegans is approximately 8 x 107 base pairs of DNA distributed across 
five autosomal chromosome pairs and either one or two sex chromosomes. This size is only 
about half that of Drosophila and is much smaller than the human genome, which is 
approximately 6 x 109. However, this is partially due to the number of repeated genes. In C. 
elegans the proportion of repeated genes is only 17 percent, while in humans the proportion of 
repeated genes is significantly higher at 50 percent (Wood, 1987). This results in about 50 
percent C. elegans genes have a homolog found in the human genome. The proteome of C. 
elegans has a more significant homology with the human proteome at approximately 83 percent 
(Lai et al., 2000). This means that the proteins made by the genes in C. elegans are very similar 
to the proteins in humans, despite their drastically different levels of complexity and 
functionality. 
The sex of a nematode is dependent upon the sex chromosome arrangement. If there is a 
pair of X chromosomes, the nematode is a hermaphrodite. Hermaphrodites are capable of self-
fertilization by performing both spermatogenesis and oogenesis, the former of which occurs 
earlier in the life cycle. The other sex of C. elegans is a male with the ability to perform 
spermatogenesis. The sperm produced by males is able to inseminate the hermaphrodites. 
However, the population ratios do not favor the male sex, as fitness dictates that self-fertilization 
is more favorable. As such, less than one percent of hermaphrodite offspring is male. 
Additionally, when males inseminate a hermaphrodite the result is a 50 percent split between 
males and hermaphrodites (Gilbert, 2013). Therefore, it is easy to control the population to a 
desired sex. 
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 Genetic Engineering Capabilities 
The occurrence of recombination is found in oogenesis and spermatogenesis, in both 
males and hermaphrodites. However, due to the higher frequency of recombination in 
hermaphrodites, due to two sex chromosomes, the hermaphrodites have been studied more in 
depth. The rate of recombination increases with temperature and decreases with age of the 
nematodes (Wood, 1987). This means that spermatogenesis produces the most recombination 
early in the life cycle of a C. elegans. This takes place during the hermaphrodite’s molting 
transitions to allow for oogenesis when it matures. Mutations usually occur on the autosomes and 
so those are targeted when genetically engineering nematodes. 
One way to induce mutations is through the use of ethyl methanesulphonate (EMS). EMS 
is a monofunctional alkylating agent that has a rate of mutation of 5x10-4 per gene (Wood, 1987). 
There are a number of other mutagens for random mutation, but EMS was the most common due 
to it being a method from Brenner. Recent developments have been made in genetic engineering 
to insert genes into the C. elegans genome, which can be performed by utilizing the CRISPR 
associated protein 9 (Cas9) (Waaijers et al., 2013). Cas9 has the ability to target certain 
sequences in the genome and break the double strand of DNA to insert genetic information. 
While this method is a relatively new development, it holds promise for gene targeting success in 
the future. 
2.2.4 Research Applications 
This section provides an overview of different applications that C. elegans have been used for, 
demonstrating the tangible benefits as a model system.  
C. elegans have proven to be an ideal animal model for high throughput screening in 
order to discover effective pharmaceutical therapies, chemicals, or even toxicology that have 
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 neural or behavioral effects. C. elegans have been utilized for many high throughput drug 
discovery applications, thus replacing the labor and resource extensive cell based systems, due to 
their 60-80 percent homology to humans, genetic tractability, and versatility (Gosai et al., 2010; 
Riley et al., 2014). Various experiments have been conducted for drug discovery for 
neurodegenerative disorders such as Alzheimer's, Parkinson's disease, and Huntington’s disease, 
amyotrophic lateral sclerosis, frontotemporal dementia, and spongiform encephalopathics (Gosai 
et al., 2010). Generally, these experiments are run with various strains of mutated C. elegans to 
mimic the symptoms of the specific disorder to accurately evaluate drug efficacy and absorption, 
distribution, metabolism, excretion, and toxicity (ADMET) (Riley et al., 2014). 
C. elegans are also useful for various chemical genetics applications. Researchers are 
able to fast forward and reverse genetic tools to identify drug targets and understanding the 
mechanism of action of specific drugs using C. elegans. For example, feeding C. elegans with 
bacterial expressing dsRNA alter the C. elegans gene expression. This type of experimentation 
has induced genome-scale chemical genetics examination (Riley et al., 2014). Figure 6 below 
shows various types of C. elegans research methods including: morphology, locomotion, 
immobilized fluorescent imaging and live fluorescent imaging. Each of these methods would be 
applicable to different neurological and behavior studies. For example, the first instrumentation 
method listed would be for behavior C. elegans studies while, the second and third 
instrumentation methods would be for neurological C. elegans studies (Riley et al., 2014) 
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Figure 6: Various applications for C. elegans research including the instrumentation, phenotype/assays, 
advantages and disadvantages (Riley et al., 2014) 
 
2.3 Chemical Screening 
Chemical screening is a method for high-throughput experimentation, commonly used in 
drug discovery. Here we explain how chemical screening experiments are currently conducted, 
what methods are used, and what methods can be used in the future. 
2.3.1 Manual Process of Chemical Screening for C. elegans  
This section discusses the current system used for the chemical screening of C. elegans. 
Additionally, it includes an overview of the protocols used to create microfluidic arenas and 
conduct neural imaging (Ca2+) experiments.  Finally, a brief review of the mathematical models 
used to quantify neural responses is provided. 
 For current chemical screening applications using C. elegans, the gold standard for high-
throughput behavioral and neurological studies is the manual screening approach. Described by 
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 Larsch et al. and Lagoy & Albrecht, microfluidics are a useful way to record and analyze C. 
elegans. This method involves the use of transparent, polydimethysiloxane (PDMS) microfluidic 
devices to house C. elegans, which provide complete visualization of the worms. These devices 
allow for the collection of data from a large number of animals, as some devices are capable of 
housing up to 100 nematodes. Additionally, they can be used with both bright-field and 
fluorescent microscopy, enabling the study of behavioral and neurological responses, 
respectively. Pure laminar flow and the minimal amount of liquid contained in these devices 
allows for rapid and reliable switching of liquid stimuli. 
 The process of fabricating PDMS devices is relatively inexpensive and can be used to 
produce arenas with varying features. The process begins with soft photolithography 
microfabrication to create a silicon wafer master mold, which is described by previous methods 
(Larsch et al., 2013). The physical process of producing a silicon master is minimally time 
consuming (2-3 hours), however the creation of photomasks with the correct dimensions can take 
many iterations. Fortunately for our applications, optimal photomasks for the production of 
devices to study young adult C. elegans have been developed.  Upon completion of the 
microfabrication protocol, PDMS mixture (10:1 ratio of polymer-to-crosslinking agent) poured 
over silicon wafer in a large diameter petri dish, degassed, and baked to elicit crosslinking 
(Lagoy & Albrecht, 2014). Devices are then cut out of the dish using a scalpel and carefully 
separated from one another along borders using a razor blade. Inlet, outlet, and worm loading 
ports are created using a 1mm dermal punch. These methods have been previously described by 
Lagoy & Albrecht, and a schematic of the PDMS device fabrication is shown below in Figure 7. 
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Figure 7: Polydimethylsiloxane (PDMS) device fabrication (Lagoy & Albrecht, 2014) 
  Once the devices are cut out from the complete PDMS mold and punched, they are 
washed using ethanol and water, and dried with compressed air. They are then placed between a 
fluorinated piece of glass (arena side of PDMS) and an untreated piece of glass (top side of 
PDMS device), sealed using a clamp system, and degassed prior to conducting experiment 
(Figure 8). 
 
Figure 8: PDMS device for experimental use (Lagoy & Albrecht, 2014) 
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   For screening applications, chemical stimuli are drawn by gravity through the 
microfluidic arena containing C. elegans. This setup involves pipetting liquid chemicals into the 
wells of a 96-well plate, loading the worms into the arena, establishing flow of the chemicals 
through the device, and recording the behavior or neurological responses using a microscopic 
camera (Larsch et al., 2013). A schematic overview of this system is displayed in Figure 9 
below.  
 
Figure 9: Schematic of manual chemical screening assay 
 Depending on the use of bright-field or fluorescent microscopy, the behavior or 
neurological responses of C. elegans can be recorded for computational analysis. For behavioral 
studies, the movement of worms can be analyzed using MATLAB, and the average behavioral 
responses to chemical pulses, stripes, and gradients can be quantified (Larsch et al., 2013). The 
chemical screening method that our project aims to augment with an automated robotic system, 
32 
 
 involves the quantification of neural responses to a library of chemical stimuli. As previously 
reported, ImageJ, which is a scientific image analysis software developed by the National 
Institutes of Health (NIH), can be used to assess the intensity of fluorescently labeled neurons in 
C. elegans (Schneider, 2012).  This is used to study dynamic calcium activity in the neuron of 
interest, which indicates the signaling activity of the cell/neural pathway. As shown in Figure 10 
below, the neural activity of each particular animal can be distinguished, which allows for the 
establishment of a baseline of fluorescent intensity for each worm (Larsch et al., 2013). This 
baseline is important for determining the overall change of intensity, thus the varying degrees of 
response between different worms.  
 
Figure 10: ImageJ analysis of calcium activity of C. elegans AWA neuron in response to 1μM diacetyl 
(Larsch et al., 2013) 
 For the images analyzed in Figure 10 above, the worms were paralyzed using a drug 
called tetramisole (Larsch et al., 2013). The inclusion of this paralyzing agent allows for better 
neural analysis using ImageJ, because the worms move very little, making it easier to 
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 consistently distinguish them from one another. While this method provides more stable data 
collection, it is not ideal due to the somewhat unknown additional effects of tetramisole, as well 
as the prevention of free movement. One of the greatest advantages of utilizing microfluidics for 
C. elegans research, is that their behavior can be assessed in a systematic manner; paralyzing the 
worms is somewhat contradictory to the overall goal of being able to study worms in as close to 
a native environment as possible. Calcium imaging tracking software, NeuroTracker 1.0, was 
developed in an attempt to overcome the problems associated with tracking the neural activity of 
freely moving C. elegans. This system was accompanied by a number of limitations, including 
large generation of data and the inability to distinguish worms from one another, both of which 
pose problems for high-throughput applications (Cupido, Feng, & Hess, 2014). To address these 
issues, the previous MQP developed a revised code called NeuroTracker 2.0, which allows for 
improved automation and enables the collection of neural data from up to 20 freely moving C. 
elegans. 
Together the manual system for chemical screening and NeuroTracker 2.0 provide a good 
setup for high-throughput drug discovery research using C. elegans. The major limitation with 
this system is the reliance on manual operation of the chemical switching, which our design aims 
to augment. 
2.3.2 Automated Systems  
This section reviews the automated systems, both for liquid handling and C. elegans research, 
which have been explored. 
Existing systems for automated fluid delivery 
 The existing systems for automated fluid delivery are expensive, designed to only 
transfer liquid, and are not easily modified. For example, the Precision Microplate Pipetting 
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 System from Biotek, which uses eight pipetting tips that are able to fill a 96-well plate from a 
single reservoir (Larson, 2012). After the system is programed, it can be unattended for the 
duration of the liquid delivery to the desired plate. The system is able to dispense liquid, mix 
within the well (similar to a micropipettor), conduct serial dilutions, and transfer samples from 
one plate to another. The system is not able to transfer liquid to non-96 well plate containers, 
which means it is not capable of transferring to a microfluidic arena. The main drawback of the 
current systems on the market is that they focus only on transfer to a plate of wells and not to 
various containers. Additionally, the Precision Microplate Pipetting System is very expensive at 
$20,000.  
Existing systems for automated C. elegans research 
 C. elegans are commonly studied due to their desirable characteristics (mentioned 
above), and there are a number of automated devices that have been designed to automate C. 
elegans analysis. One such apparatus is the BioTek MicroFlo, which is traditionally used to 
dispense specific volumes of liquid into a well plate. Although, it has also been used to dispense 
nematodes into a 96-well plate from a reservoir (O’Reilly, 2014). This system is beneficial 
because it is able to sort C. elegans in an automated fashion. However, it is not able to analyze 
them by any means. Additionally, the MicroFlo is also expensive, costing $13,000 on the 
secondary market. 
 One of the best devices on the market for analysis of C. elegans is the COPAS BIOSORT 
(O’Reilly, 2014). The BIOSORT is able to sort nematodes based on a number of parameters. By 
drawing from an entire population, the system is able to sort C. elegans based on size, number, 
and the fluorescence intensity. This system is ideal for monitoring the fluorescence of treated 
neurons in C. elegans, but the results are passive, only measuring how a reagent affected the 
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 nematode at the peak of response. Essentially, the active uptake of a reagent cannot be seen, 
limiting the experimental results. Another drawback is the price for sale for $300,000. 
 One last method used to sort C. elegans is a modified use of fluorescence-activated cell 
sorting (FACS) (O’Reilly, 2014). As the name implies, this method is typically used for sorting 
fluorescent cells. A novel method has been developed to modify existing systems to sort C. 
elegans larvae based on fluorescence, which is called live animal fluorescence-activated cell 
sorting (laFACS). FACS is able to sort up to 100,000 larvae in one hour. This is beneficial 
because one can use the same system to sort cells and C. elegans larvae instead of having 
different systems dedicated to each. However, a drawback is the size limitation, which only 
allows young larvae to be sorted, as the system is traditionally just used for cells.  
2.3.3 Arduino System 
This section introduces the Arduino microcontroller and software environment. It serves to 
relate our literature review to our project strategy, indicating the methodological route we will 
take. 
The Arduino prototyping device “is a microcontroller development platform paired with 
an intuitive programming language that you develop using the Arduino integrated development 
environment (IDE)” (Blum, 2013). The software is based off of C/C++, and it sets the stage for 
writing a computer program, which can then be uploaded to the Arduino board. 
The hardware board is based off of an 8-bit Atmel AVR microprocessor, an oscillator, 
and a voltage regulator; it “processes inputs and outputs between the device and external 
components” that can be attached to the device (McRoberts, 2013). Adding separate components 
to the system can transform this device into a dynamic, programmable control unit for almost 
any application. Some external companies, including Adafruit, TinkerKit, Annikken Andee, and 
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 Xbee, are approved by Arduino as viable producers of Arduino-compatible technology, and they 
even have products for sale through Arduino’s site (Shields/3rd Party). These extra components, 
called “shields,” are attachable circuit boards that add robust functionality to the Arduino project 
(McRoberts, 2013). 
In addition, the Arduino is fundamentally open source, meaning “all the design files, 
schematics, and source code are freely available to everybody.” Furthermore, it means that the 
Arduino software and hardware can be readily integrated into independent projects that steer 
away from the standard design protocol, and commercial distribution of these projects using 
Arduino’s designs is permitted (Blum, 2013).  
Since Arduino is a comprehensive and open-source product, its applications can vary 
greatly. Automation is well within Arduino’s capabilities in terms of mechanical and electrical 
functionality. Arduino’s online community, with its wide-reaching audience, will have the proper 
resources for our team to be able to find a suitable route for creating an automated chemical 
screening system. 
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 Chapter 3: Project Strategy 
The overall goal of this project is to create a device that enables the automated delivery of 
a chemical library to a microfluidic arena containing C. elegans nematodes. The purpose of this 
system is to facilitate high-throughput drug discovery for the treatment of neuropsychiatric 
disorders, which can be modeled using this organism. Moreover, we hope that this platform 
technology can be applied to other biological research, providing an automated alternative to 
applications such as cell culture studies, and staining. Using our background research and input 
from our project advisor, Dirk Albrecht, we have identified the following objectives and 
constraints to develop an approach to the task at hand. 
 
3.1 Client Statement 
At the onset of this project, our initial client statement was to: Create an automated 
system to improve the throughput of microfluidic experiments using C. elegans. After discussing 
the scope of the project with our advisor, and determining the current state of chemical screening 
in C. elegans, we revised our client statement to be to: 
Design, develop, and assess an automated system to improve the throughput of neurological 
screening assays in C. elegans by sequentially delivering chemicals from a 96-well plate to a 
microfluidic arena. The system must deliver chemicals with a minimum flow rate of 
0.1mL/minute and switch chemicals within one minute or less, while preventing the introduction 
of air bubbles. Additionally, the system must fit within the geometric confines of the current 
imaging apparatus. 
This revision more clearly states the scope of our project, specifically with the addition of 
"assess," "neurological screening assays," "sequentially delivering chemicals from a 96-well 
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 plate to a microfluidic arena", and the specific constraints associated with sequential delivery. 
The constraints given to us by our advisor provide minimum specifications that our system needs 
to achieve. Assessment of our system will increase the credibility of our project, since ensuring 
that the design actually works is essential to its scientific and commercial validity. 
Distinguishing the microfluidic experiments as "neurological screening assays" defines the 
experiments for which the system is intended, thus helping us tailor our system specifically to 
these experiments. The inclusion of "sequentially delivering chemicals from a 96-well plate to a 
microfluidic arena" clarifies the particular process our system aims to augment. With this goal in 
mind, we identified the following objectives and constraints, which provide a framework for the 
creation of an optimal design. 
 
3.2 Objectives 
Creating central objectives helped guide us in the design process. The objectives are 
outlined and categorized as follows: accurate, efficient, precise, safe, and user friendly. An 
objectives tree is shown below in Figure 11, which summarizes what we hope to accomplish by 
keeping each objective in mind throughout the design process. 
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Figure 11: Objectives tree containing the primary and sub-objectives 
To determine the importance of each objective in our design process, the objectives were 
ranked in a Pairwise Comparison Chart (PCC) (Table 1 below). After establishing a thorough 
description of each objective, the team began comparing them. Accurate received the highest 
ranking in the PCC, emphasizing the significance it has in our project. Our system has many 
accuracy specifications that will determine the quality of its performance while running 
experiments. The second highest ranking objective is precise. It is important for our system to be 
precise so that experiments can produce consistent and reproducible results. The third ranking 
objective is efficient. The efficiency of the system is less important than accuracy and precision 
because this objective caters to the convenience of the operator rather than to the functionality of 
the system. However, ideally the system will be hands-off with minimal effort for the operator. 
Objectives
Accurate
Proper Rinse
Correct depth for fluid 
intake
Navigated to designated 
well
Efficient
Minimal duration
Minimal operator manual 
effort
Precise Consistent, reproducible results
Safe
No chemical spilling
Proper training
User Friendly
Modular
Adaptable software
40 
 
 The lowest ranking objectives are safe and user friendly. Safety is always a concern when 
working in a laboratory, but we predict our system will not pose any danger to the operator. 
Finally, the user friendliness of the system is not as important as its overall efficacy. Our advisor, 
Professor Albrecht, discussed the importance of our objectives and helped us refine our rankings. 
The PCC analysis of our objectives establishes a foundation for further development of our 
design process. 
Table 1: Pairwise Comparison Chart (PCC) for ranking the five primary objectives 
 
3.2.1. Accurate 
In order for this system to be used for the collection of high-throughput neural imaging 
data, accuracy is imperative. For this project, accuracy means that the system remains error-free 
in its delivery of chemicals from the 96-well plate to the microfluidic arena. Thus, the automated 
chemical switches must be executed in a systematically reproducible manner. To generate viable 
results, the switches from one well to the next need to be controlled in an accurate spatial pattern 
to ensure that the chemicals are delivered in the intended order, with proper rinsing between 
different chemicals to prevent cross-contamination and a complete flush before the collection of 
data for each new chemical. Furthermore, the system needs to achieve the correct depth in the 
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 2mL well to allow for 20 minutes of fluid delivery, without the introduction of air bubbles into 
the arena. 
In summary, the sub-objectives that are encompassed by accuracy are listed below, 
ranked in order of importance (most important  least important). The sub-objectives were 
ranked based on our advisor/client’s directives. 
a. Navigates to a designated well under given commands 
b. Properly rinses between chemical switches 
c. Reaches correct depth for fluid intake 
3.2.2. Precise 
In order for our system to be used for viable data collection, it needs to be precise. For 
this project, precise means that the system must generate consistent, reproducible results. The 
experiments we conduct using the system must yield results that all fall within a reasonably 
narrow quantitative range, thus exhibiting statistical precision. 
In summary, there is only one sub-objective that is encompassed by precision, which is 
shown below. 
a. Consistent, reproducible experimental results 
3.2.3. Efficient 
To optimize the automated throughput of the system, it needs to run experiments in an 
efficient manner. Due to the time-consuming nature of manual chemical screening experiments, 
a key objective is that this system requires minimal user intervention after setup. As opposed to 
the current method, which requires the operator be present to execute the chemical switches by 
hand, an automated system would allow the operator to focus on other tasks during the 
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 experiment. Additionally, it is also important to minimize the time required for each chemical 
switch, as this prevents wasting time that could otherwise be used to collect neurological data 
from the worms. Prolonged chemical switches do not have a negative effect on the validity of the 
data, but it decreases the throughput of the system.  
In summary, the sub-objectives that are encompassed by efficiency are listed below, 
ranked in order of importance (most important  least important). 
a. Minimize time the operator spends on the experiment 
b. Minimize duration of chemical switching 
3.2.4. Safe  
In our system, safety is an important aspect. If the system poses a direct threat to the 
wellbeing of the operator, its practicality becomes questionable. Because of this, we plan for our 
system to be safely operable for any user, whether they are learning how to use it for the first 
time or have already mastered using it. This will be accomplished by ensuring that the system 
will not cause chemical spills through normal use, which could pose harm to the operator. 
Additionally, with moving parts there is always a heightened risk of mechanical failure, but for 
our design we plan to minimize the chance that such a malfunction could cause a chemical 
spillage. Furthermore, we will require that all users go through safety training before using the 
system, thus reducing the likelihood of improper use. By minimizing the risk of chemical 
spillage, mechanical failure, and improper use, we hope to prevent harmful outcomes due to 
operating this system. 
In summary, the sub-objectives that are encompassed by safety are listed below, ranked 
in order of importance (most important  least important). 
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 a. No chemical spilling 
b. Proper user training 
3.2.5. User Friendly 
Ease of use will ensure that our system is competitive with similar products that are 
commercially available. The only parts of this setup that need to be changed from one 
experiment to the next are the 96-well plate, the PDMS arena with C. elegans, and the waste 
container. Changing these parts will be very intuitive so that proper setup is logical. 
Additionally, the software that will control the apparatus will also be easy to use and 
customizable so that the running of experiments will not be cumbersome. 
In summary, the sub-objectives that are encompassed by user friendly are listed below, 
ranked in order of importance (most important  least important). 
a. Ease of setup 
b. Adaptable software 
 
3.3 Constraints  
As outlined by our advisor, the four categories of design constraints are physical, 
financial, efficacious (or experimental), and temporal. The only physical constraint is that the 
design must fit within the geometric confines of the existing imaging apparatus in Professor 
Albrecht's lab. Since we will be designing moving components that will attach to an existing 
apparatus, we must take precautions so as to avoid collisions of any components of the system 
with the existing apparatus. 
The only financial constraint is our budget of roughly $500. 
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 For efficacy, there are four distinct constraints. Switching between each individual 
chemical well must occur within one minute; furthermore, when switching between each 
chemical, a 0.01% carryover rate is the highest value that is acceptable for our purpose, since 
mixing multiple chemicals together can corrupt the collected data. Air bubbles must be prevented 
from entering the microfluidic arena during each chemical switch, so that there are no random 
gaps in the stimuli. Additionally, each individual 2 mL chemical well must last for 20 minutes, 
so the system must allow for a minimum flow rate of 0.1 mL/minute. 
Lastly, the temporal constraint is that we finish the entire project within the allotted MQP 
timeframe. Table 2 below shows a visualization of the categorization of these constraints. 
Table 2: Constraints organized into categories 
Financial • Budget must not exceed $500 
Physical • Must fit within the geometric confines of the imaging apparatus 
Efficacy 
• Chemical switching must occur in less than 1 minute 
• Allow for a minimum flow rate of 0.1 mL/minute 
• Air bubbles must be prevented during chemical switch 
• 0.01% chemical carryover across wells 
Time • Finish within MQP timeframe 
 
3.4 Project Approach 
 In order to accomplish the goals set out for this project, we devised a project approach to 
which we plan to adhere. We have separated our project goals into two categories: design and 
validation. The design component of our project includes completing the existing microscope 
apparatus in Dr. Albrecht’s lab. This involves constructing a method of chemical extraction from 
the 96-well plate by means of z-axis motion; the x- and y-axis components to the motion 
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 involved in chemical extraction from the 96-well plate have already been designed and created 
by Dr. Albrecht. 
The 96-well plate is attached to the apparatus using an aluminum holder that we 
developed, and is moved in a Cartesian-coordinate system, in the plane parallel to the lab floor, 
using Arduino software and a DC stepper motor. The chemicals should then be extracted from 
the plate using rigid tubing and height difference, to manipulate the liquid to move downwards 
into the arena. We use Arduino-controlled components to carry out this z-axis motion, since the 
x- and y-axis components were both already operating through the same technology. We believe 
using Arduino technology for all movement involved with chemical extraction streamlines the 
design and use of the apparatus as a whole. 
The validation portion of our project involves conducting initial experiments to ensure 
that the apparatus meets all of the fundamental design objectives and constraints. Following this 
preliminary assessment, we will conduct previously studied neural screening experiments, to 
ensure that this apparatus is able to reproduce the results obtained using the existing methods. 
We hope that after the completion of our project, the overall experience and results of conducting 
high-throughput chemical screening experiments using Dr. Albrecht’s apparatus will be more 
robust, hands-off, and reliable than through the current manual method. 
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 Chapter 4: Alternative Designs 
Using our objectives, constraints, and project approach that we previously outlined, we 
began the process of bringing our device to fruition. We researched potential pieces and methods 
that can be used to complete the apparatus, in accordance with the previously established 
functions, needs, and specifications. We brainstormed alternative designs and compared them to 
each other, weighing out the advantages and disadvantages of each, in order to decide upon a 
final design concept. We then modeled the physical setup of the apparatus as a whole in 
SolidWorks to ensure that everything would fit together and move properly. Finally, we discuss 
the experiments we will conduct to ensure that the apparatus closely follows the guidelines 
previously set for our design, while still maintaining functionality. 
 
4.1 Needs Analysis 
In terms of the results of our design and the preferences associated with them, set by our 
advisor, the experimental constraints are the “needs” of our design. To reiterate, switching 
between each chemical must occur in less than one minute, the setup should allow for a 
minimum flow rate of 0.1 mL/minute, air bubbles must be prevented during chemical switches, 
and there must be no greater than 0.01% chemical carryover across the wells. After meeting with 
our advisor, it was clarified that chemical switches must actually occur within a matter of 
seconds, and not just within one minute. Therefore, we sought to find a robotic component that 
prioritizes speed and accuracy of movement, in order to accommodate for this slight change in 
constraints. 
As for the “wants” of our design, these are the experimental objectives we previously 
outlined. These entailed that the apparatus and the experiments carried out are accurate, efficient, 
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 precise, safe, and user-friendly. Table 1 and Table 2 display visual representations of the relative 
importance of these characteristics. 
Additionally, in order to complete the apparatus, our team has to design a platform that 
will hold the 96-well plate when it is going through chemical switching. To do this, we need to 
think about how this piece will fit into the overall apparatus spatially and then we will create a 
model using SolidWorks computer-aided design software, so that we can analyze how the 
different parts will fit and move together. As delineated by our advisor, this holding platform 
cannot be heavy, should not deform easily, and must have as little ground clearance as possible 
between the microscope platform, to minimize the tube length at the 96-well plate/microfluidic 
arena interface. Therefore, we will need to find materials and a design that fit these criteria. 
 
4.2 Conceptual Designs 
The final design was heavily dictated by the experimental constraints and suggestions 
from our advisor. At first there were a number of ideas that made use of different methods and 
were analyzed, but as the constraints became more defined the design took a more definitive 
shape. At the outset, since the x- and y-axis components were already constructed using Arduino 
hardware and software, we considered using the same technology for the z-axis motion ideal. 
However, since these components were already constructed, it left us with a limited space to 
work within. 
The 96-well plate holder could not be higher than the moving platform, so we decided 
that a two-piece holder secured together by screws was the best design. This was intended to 
limit the amount of material needed, and allowed for more structural integrity, compared to 
soldering two pieces together. 
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 Next, we analyzed the method by which to obtain the liquid from the 96-well plate 
through the z-axis. This component must accommodate rigid tubing, for fluid delivery from the 
96-well plate to the microfluidic arena, and perform fast chemical switches, as stated in the 
constraints. Our design options for the z-axis motion, along with explanations of our decision 
processes for each, are detailed below. For each option, we wanted to capitalize on the design 
objectives we described previously, while keeping our constraints in mind. 
Linear Actuator 
With rigid tubing and the need for quick switching, we posited that a miniature linear 
actuator would be ideal to move the tubing. However, the commercial options available for this 
device were limited in options for length and speed. Moreover, it is expensive and very heavy, so 
we opted to find different design ideas. A visual representation of this design is shown below in 
Figure 12. 
 
Figure 12: Conceptual drawing of the linear actuator 
49 
 
 Elevating Platform 
We considered an elevating platform, which essentially was a lab jack placed on top of 
the 96-well plate holder, and underneath the plate itself. This eliminated any need for attaching 
the tubing to any moving part, since the x-, y-, and z-axis movements would all be controlled by 
the motion of the plate. However, this was also a very bulky design and we feared it would 
increase the risk of chemical spills onto the apparatus, since the entire plate would be constantly 
moving. Additionally, this component is a rather costly one, so if we chose to pursue the idea, we 
would design our own 3D-printed version in Solidworks and have it machined in steel or 
aluminum. Still, this would be heavy and thus susceptible to excessive spillage since such large 
parts would be moving rapidly in each axis, seen below in Figure 13. 
 
Figure 13: Conceptual drawing of the elevating platform design 
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 Rotating tire 
The rotating tire design includes the use of one servo motor and two tires. This design 
will be oriented horizontally and feed the tubing in-between the two rotating tires. The servo will 
control the movement of the tubing. The tubing will also be held in place on the base of the 
design to prevent it from moving out of place on either side. The conceptual drawing of this 
design can be seen below in Figure 14. This design will be inexpensive, however it is likely to be 
inaccurate. 
 
Figure 14: Conceptual drawing the rotating tire design 
 
  
51 
 
 4-Link Hinge 
 The 4-link hinge design will include four joints and a servo motor. As the servo motor 
rotates 180 degrees at a fixed link it, will force the other links to move accordingly (up or down 
at the same degree), seen in Figure 15. The tubing will be attached to the moving links and sway 
under the given servo commands. This design will be inexpensive, but the swaying of the tubing 
will cause inaccurate movements.   
 
Figure 15: Conceptual drawing of the 4-link hinge design 
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 Screw 
We also considered the screw design, which includes the use of a stepper motor and 
various machined parts. The stepper motor would spin the threaded “screw” machined 
component in order to move the attached “nut” component up and down. The tubing will be 
attached to the “nut” part of the design and held vertically in a casing, Figure 16. We analyzed 
this design and it will be expensive with all of the custom parts and will need a lot of testing 
prior to its use. 
 
Figure 16: Conceptual drawing of the screw design 
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 Pulley 
We also analyzed the design concept of a pulley, with a belt running around two separate 
wheels arranged along the z-axis, and the tubing attached at two points along the belt in order to 
secure it, but not force it to snap, seen in Figure 17. The movement of the wheels would be 
controlled by a micro servo motor, which is very fast and inexpensive. Overall, this design would 
be very tall, consuming a considerable amount of space along the z-axis, but not as bulky in 
terms of surface area in the x- and y-axes. Moreover, the micro servo motor itself is very light, 
and the accuracy of its movement is high. 
 
Figure 17: Conceptual drawing of the pulley design. 
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 Slide Potentiometer 
Taking all of these options into account, the linear actuator was effectively the most ideal 
option, save for the high cost and bulkiness. We opted to find a lightweight, inexpensive version 
of this device and encountered the motorized slide potentiometer (slide pot). This option was 
smaller, relatively lightweight, fast, very reasonably priced, and capable of position sensing, 
which is crucial to our design. Since this discovery proved to be very promising, we pursued it 
further. Shown below is an image of this product. 
 
Figure 18: Slide potentiometer from Sparkfun Electronics. 
 
In order to optimize our design, we had to consider the specifications for each design we 
conceptualized. The specific factors we considered included range of motion, relative accuracy, 
speed, cost, control system, and which motor is included in the design. We estimated range of 
motion based on information provided by motor data sheets or through calculations, if the motor 
would be incorporated in a system we developed. Accuracy was qualitatively approximated 
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 based on how we believed the system would perform the required tasks. The speed was 
evaluated using data sheets; for systems that would have required us to build a motor, we did not 
include a speed value, as we did not know the specific dimensions of the system. The cost of 
each system was approximated based on the motor and additional materials required. The control 
system and motor categories were both dictated by the type of motor being implemented. A 
summary of each of these specifications can be found below in Table 3. Prior to conducting these 
experiments, we will prioritize our design choice based on the holistic optimization of 
specifications, including the relative qualitative characteristics. 
Table 3: Design Specifications to Facilitate Optimization 
Z-axis 
Movement 
(50mm) 
Linear 
Actuator1 Pulley Screw Platform
2 Rotating Tire 
4-Link 
Hinge Slide Pot 
Range of 
motion 10-100 mm 100 mm 100 mm 100 mm 100 mm 100 mm 100 mm 
Accuracy High Medium- High Medium Medium Medium 
Low-
Medium Medium 
Speed 23 mm/s 123 mm/s <100 mm/s <100 mm/s 123 mm/s 123 mm/s 200 mm/s 
Cost $70-90 ~$30 ~$30 ~$75 ~$30 ~$30 $19.95 
Control 
system 
Direct 
position 
Direct 
position 
Direct 
position 
Direct 
position 
Direct 
position 
Direct 
position 
Motor 
speed 
control 
Motor Internal stepper 
Servo3 
(13.6g) 
Stepper4 
(200g) 
Stepper/ 
High 
torque 
servo5 
Servo Servo DC 
 
1 http://www.firgelliauto.com/products/high-speed-actuator 
2 http://www.ctechglass.com/ctech-lj2503-p-47.html   
3 http://www.rakuten.com/prod/neewer-mg90s-metal-gear-rc-speed-torque-micro-servo-9g-for-trex-
align/275316982.html?listingId=375596357&sclid=pla_google_NeewerDirect&adid=29963&gclid=CIS38sH2z8ICFchr7AodCkIAtg 
4 http://www.adafruit.com/products/324?gclid=CNz7rez3z8ICFcXm7AodgH8A9g 
5 http://www.gpdealera.com/cgi-bin/wgainf100p.pgm?I=FUTM0654 
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 4.3 Functions (Specifications) 
After constructing the chosen design, we will conduct validation tests to make sure that 
the design is properly fulfilling each constraint specified by our advisor. Table 4 below outlines 
these tests. In order to quantify chemical crossover, we will fill each well with water in place of a 
chemical, and we will use spectroscopy, which is a method of determining the concentration of a 
substance present in solution by measure the way light is absorbed or reflected through the 
liquid, a pH test after dissolving a solute in each well (for example, salt), or gas chromatography, 
which is a way to determine the chemical purity of a solution. To sense pressure feedback when 
the tube is inserted into the well, in order to make sure the tubing does not hit the bottom of the 
plate, we can either place a very sensitive pressure sensor underneath the plate and have a 
continuous reading of the pressure available, or we can monitor the feedback from an actuator 
attached to the tubing. To ensure proper flow rate, trial and error is an option, in which we will 
adjust the height of the 96-well plate to approximately adjust the flow rate. We can also calculate 
the flow rate across the arena, since it is constant, using the volume of the liquid and the distance 
across the arena. Additionally, we could calculate the flow rate through the tubing using the 
height of the column and the density of the liquid. Lastly, to ensure proper speed of chemical 
extraction, we can record the change in height over time using imaging software, or we can 
attach a marker at a certain position on the tubing and use visual confirmation that it is moving at 
an appropriate speed. 
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 Table 4: Function-Means (Morphological) Chart for Validation Tests 
Function Means 1 2 3 
Quantify chemical 
crossover Spectroscopy pH test Gas chromatography 
Sense pressure 
feedback 
Pressure sensor 
under plate 
Feedback from 
tubing actuator ••••• 
Ensuring proper flow 
rate Trial and error 
Calculate flow rate 
across arena 
Height and density 
calculation 
Ensure proper speed 
Record and analyze 
change in height over 
time 
Visual confirmation 
of flow through 
tubing 
••••• 
 
4.4 Feasibility Study/Experiments 
 To assess the feasibility of the developed system, there are a number of studies that must 
be conducted. These experiments range from those that ensure the fundamental design objectives 
and constraints are met, to those that determine the system’s ability to successfully reproduce C. 
elegans chemical screening assays. These procedures were introduced in Section 4.4, but we will 
go into greater detail about our experimental protocols in this section.  
To prove that our design is a feasible solution to the problem being addressed by this 
research, there are a number of explicit benchmarks that must be assessed. These milestones 
include the quantification of chemical crossover, the determination of pressure feedback, the 
establishment of proper flow rate, and the verification of timely switches between chemicals. To 
analyze these parameters, we will evaluate the means presented above in Table 4.  
To quantify the rate of chemical crossover, we will use either spectroscopy or a pH test. 
We anticipate that these means will be reliable and provide a timely and cost-effective way to 
assess our system. Both of these means involve similar experimental protocols; we will load a 
96-well plate with either a dye of known concentration or a salt solution of known pH. These 
solutions will represent the “chemical” being studied for level of crossover. The first column of 
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 the well plate will alternate between “chemical” and distilled (DI) water, and the second column 
will be filled with the same stock of DI-water used in column one. With this protocol, we should 
be able to measure the level of dye carried from the first “chemical” well to the second, after it 
has been rinsed. This will be determined using spectroscopy to measure the concentration of dye 
in the second well (which should be just DI-water) after the tubing has been moved to it, or by 
determining the pH of the liquid in this well. 
As discussed in the previous section, we will measure the degree of contact between the 
tubing and the bottom of the 96-well plate using either a sensitive pressure sensor or by direct 
feedback from an actuator. This evaluation will depend on which final design we choose to 
implement for the z-axis movement. If we use one of the design options that utilizes a servo 
motor, we will likely have to use the pressure sensor, as the motor will likely not have feedback 
capabilities. Some of the linear actuators we have researched include a feature for feedback, 
therefore if we choose to implement on of these motors, we may not need an external pressure 
sensor to conduct this preliminary measurement. 
Our assessment of flow rate through the microfluidic arena will be mathematically 
evaluated and confirmed with trial-and-error experimentation. We will utilize all three of our 
means for this research, beginning with a mathematical calculation of flow rate, followed by a 
measurement of the flow rate across the arena, and finally by observing the amount of liquid that 
passes through the system over a specific duration of time. To measure the flow rate across the 
arena, we will pulse dye through the microfluidic arena and quantify the time it takes to pass 
from one side to the other. In a similar manner, we will flow liquid through the system for a 
specific duration of time (e.g. 1-10 minutes) and measure the volume that accumulates in the 
outflow reservoir. This final step will allow us to adjust the height difference of the inflow and 
59 
 
 outflow locations to optimize the flow rate of the system (i.e. 0.01 mL/min). Our preliminary 
studies will also involve testing the flow rate when the system is operating under experimental 
conditions. These tests will include determining the duration each well can be drawn from and 
confirming that the flow rate remains constant after each chemical switch. 
Our final preliminary study will be to evaluate the speed of chemical switches. This 
parameter has been thoroughly investigated in our search of an optimal z-axis component for the 
automated system. Once this component is incorporated, we will quantify the rate at which the 
movement from one well to the next occurs, by recording the switch and analyzing the video. 
This will also be studied by determining the rate at which one “chemical” clears the arena and is 
replaced by another. This will likely be conducted by alternating a clear liquid (i.e. S. basal 
buffer) with a buffer containing dye. 
Upon completion of the preliminary studies used to ensure that all of design constraints 
are met, we will conduct experimental studies using C. elegans. The initial experiments will 
involve repeating a chemical screening assay that has been previously studied using the manual 
method. This comparison will allow us to assess our system’s ability to reproduce scientific data, 
which is needed to draw the conclusion that it is a successful alternative to the manual method, 
which is the current gold standard. We will likely reproduce a small-scale version of the AWA 
chemical screen presented by Larsch et al., in which neural responses to a range of chemical 
molecules were assessed by quantifying change in fluorescent intensity.  
4.5 Modeling 
In order to test the validity of our designs we created SolidWorks models. The current 
system was assembled using parts from OpenBuilds online resource center, such as the gantry V-
slot plate, the V slot bars, wheels, and screws seen in Figure 19. The initial automated system, 
60 
 
 built by our advisor, was responsible for x- and y-axis movement. Our project addresses the z-
axis movement and creates a platform to hold a 96-well plate during testing. The modeling 
system is used to test the physical constraints and barriers surrounding the platform and z-axis 
design components.  
 
Figure 19: Current automated system, responsible for x and y axis movement, in Solidworks 
 
In SolidWorks, we were able to accurately model the size and dimensions of the 96-well 
plate platform, shown below in Figure 20. This model will be 3-D printed and attached to the 
current system to determine if there are any spacial constraints that SolidWorks did not display. 
Figure 21 displays the 3-D printed platform integrated with the system.  
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Figure 20: 96-well plate platform model for 3-D printing 
 
 
Figure 21: 3-D printed platform model with 96-well plate and current x- and y-axis system 
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 To assess the preliminary SolidWorks design of the 96-well plate platform with the 
current apparatus, the model 3-D printed in Worcester Polytechnic Institute’s rapid prototyping 
lab is shown in Figure 22. The printed model was then screwed and secured in to the designated 
V-slot plate.  
 
Figure 22: Preliminary 3-D printed platform 
After testing the 3-D printed model with our current system, we will machine the 
finalized platform from compressed aluminum. In order to machine this platform, it needs to be 
split into two components to conserve material and minimize cost. The two components include 
the arm and the base seen in Figure 23.  
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Figure 23: The base and arm of the platform model that will be machined as the final product 
Before machining the base and arm of the platform, we evaluated the 3-D printed model 
and created another model of the machined part with the current system (base-teal, arm-gray), 
shown below in Figure 24. 
 
Figure 24: Machined base and arm model with the x and y system 
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 4.6 Preliminary Data 
4.6.1 Load Test from SolidWorks 
Upon integrating the preliminary 3-D printed platform with the current apparatus, the 
platform deformed under the weight of the 2ml 96-well plate. This deformation caused the 
platform to collide into various parts of the imaging apparatus. A new design was created as a 
solution to the deformation. The base of the plate was made 2mm thicker (from 3mm to 5mm), a 
taller wall was inserted along the back of the platform (height of 7.5mm) to prevent medial 
bending, and the arm was thickened to absorb more of the stress applied by the force. The 
stresses of the new design can be seen below in Figure 25. The dimensions for this platform can 
be seen in Appendix D. 
 
Figure 25: Stress Present of Updated 96-Well Plate Holder Design 
 
Figure 26 below displays the newly rendered platform with ABS plastic material, under a 
force of two Newtons. The scale bar to the right of the platform displays the location of 
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 maximum displacement the platform will experience under a 2N load. The maximum 
displacement ~ 1.1mm is shown in the far corner of the platform. Since the displacement does 
not exceed 1.1 mm, the platform will not collide with the imaging apparatus. 
 
Figure 26: Displacement of the Updated Platform made of ABS under the Force of 2N 
 
 After this modeling, we went ahead and 3-D printed the holder once again. The final 
product can be seen below in Figure 27. 
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Figure 27: Updated 96-well Plate Holder 3-D Printed 
 
4.6.2 Arduino and Slide Potentiometer 
To test the speed and strength of the slide pot, we first connected a 9 volt battery to its 
terminals and switched the polarization of the battery back and forth to qualitatively observe how 
fast the slider moved from one extreme of the track to the other extreme. We determined the 
speed was adequate, so we proceeded to crudely test the strength by suspending the slide pot, 
with a sharpened piece of tubing attached to the slider, above a 96-well plate covered with plastic 
seal, and switching the terminals of the battery so that the slider would shoot downwards and the 
tubing would pierce the seal. The outcome was satisfactory, as the seal was pierced almost every 
try, so we continued to test the speed and strength of the slide pot more accurately, using 
Arduino software and hardware. 
Initially, we tested the integration of the slide pot with Arduino software and hardware by 
connecting it to the Uno microcontroller board. This test performed the same motion as our first 
test, shooting from one extreme of the track to the other extreme. Refer to Appendix A for the 
sketch containing the code used for this test. 
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 Per our advisor’s suggestion, we used the position sensing functionality of the 
potentiometer on the slide pot. This facilitated the accuracy of its movement when we 
implemented Arduino code to control it. Each position on the track of the slide pot was assigned 
a number 0 through 1023. Our goal was to move the slider from position 0 to roughly position 
400 as quickly and precisely as possible, stay at that position for several seconds (however long 
it takes the x-axis and y-axis movements to complete), and then move from position 400 to 
position 0 as quickly and precisely as possible, without overshooting or ricocheting backwards at 
any point throughout this process. Since we had already tested that the slide pot was strong and 
fast enough, we wanted to make sure it could reach those same criteria while traveling a smaller 
distance both ways; after adjusting parameters such as the position of the origin and the speed, 
this result was satisfactory. Refer to Appendix B for the sketch containing the code for this test. 
Also per our advisor’s suggestion, we used the Arduino Motor Shield Rev3 to facilitate 
the controls of the slide pot’s DC motor. This motor shield is based off of the L298, which is a 
dual full bridge driver that takes transistor-transistor logic levels as an input, and in turn “drives 
inductive loads such as relays, solenoids, DC and stepping motors” (L298 Dual Full Bridge 
Driver). The motor shield independently controls each attached motor’s speed and direction, and 
it can control two DC motors, or one stepper motor. 
After conducting simple tests using a digital multimeter to measure the voltage passing 
through the motor shield and confirm that it is compatible with the voltage levels passing 
through the setup, we combined all of our z-axis components with our advisor’s previous work, 
so that the slide pot could run off of the same Arduino Uno that controlled the x- and y-axis 
system. Following this, we combined the code that controlled the x- and y- axis system with our 
code as well. 
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 After combining the components together, we realized powering the slide pot with 
household electricity, versus a 9 volt battery, resulted in very fast and powerful movement, to the 
point where we needed to reduce both, or at least find a way to buffer the slide pot’s movement. 
We attempted this by changing the parameters of the code once more, creating a buffer in the 
code, and creating a small physical buffer at the bottom of the slide pot as well. Ultimately, our 
code setup included a function in which the slider would slow down as it approached its 
destination. Refer to Appendix C for the sketch containing the code used for the entire apparatus. 
Once we determined our integration of each component to be satisfactory, we focused on 
combining the Arduino code of the x-, y-, and z-axis components with the software controlling 
the microscope, Micro-Manager. When the Arduino-controlled system’s movement completes, it 
sends a signal to Micro-Manager, which streamlines the timing of each movement. 
4.6.3 Z-Axis Mounting 
After coordinating the x-, y-, and z-axis movement came the task of mounting the z-axis 
component and connecting the tubing to it. As a preliminary test, the slide potentiometer was 
secured to a ring stand and the rigid tubing was attached to the moving part of the slide 
potentiometer using tape. Once the principles behind that test were confirmed, a more permanent 
mounting solution needed to be established. 
To suspend the device an appropriate distance above the 96-well plate, an apparatus 
consisting of three stainless steel bars was constructed. The bars were secured together with 
cross bar holders and then attached to the entire imaging apparatus, as seen in Figure 28 below. 
The cross bar holders are adjustable so that the height of the horizontal bar can be changed. The 
bars were also sawed to a shorter length so as not to protrude unnecessarily. 
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 The slide pot has two mounting holes in it, two centimeters apart from each other, so that 
it could be secured to another device. A piece of sheet metal was acquired and cut into a triangle, 
in which we drilled three holes, two small ones, two centimeters apart and one large one, so that 
it would secure the potentiometer and be connected to the mounting bars. To incorporate the 
slide pot for z-axis movement, we connected the slide pot to the aluminum triangle, and the 
aluminum triangle to the horizontal mounting rod, securing it over the 96-well plate, as shown in 
Figure 28 below. We connected the slide pot to two of the holes we drilled at the vertices of the 
triangle, using nuts and bolts of sufficient size for fixation. The third vertex was connected to a 
small mounting rod, which was fixed with another cross bar holder. We were able to change the 
specific location of the slide pot by adjusting the position of each mounting rod with respect to 
the cross bar holder.  
After that was accomplished, the tubing needed to be attached to the potentiometer. To 
make sure that the rigid tubing would not bend upon contact with the plastic seal, it was decided 
that placing the tubing into metal hypodermic tubing would ensure that no bending would occur. 
The hypodermic tubing would also be able to be permanently mounted to the slide pot and the 
tubing would easily be changeable. The hypodermic tubing was selected to make for a secure fit 
and was long enough to make sure the tubing could hit the bottom of the well with no 
detrimental bending of the tubing. Upon choosing the best fitting hypodermic tubing, which was 
2 inches in length and has an inner diameter of 0.061 inches, a portion was carved out using a 
Dremel tool so that the tubing could be inserted in the middle of the tubing so as to minimize the 
length it took to reach the microfluidic arena.  It was then secured to the moving part of the slide 
pot using malleable wiring. The entire setup can be seen below in Figure 28.  
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Figure 28: Slide pot and rigid tubing mounting setup 
4.6.4 Initial Dye Test 
To assess the functionality of our assembled automated system, we conducted an initial 
dye test. This experiment involved executing a series of well switches, alternating between dyed 
water and clean water. The purpose of this study was primarily to confirm the ability of our 
system to work given a set of sequential commands. Our plan was to flow dye from well A1 
through the microfluidic system, then to stop the flow, switch to well B1 to rinse, and continue 
on to well A2, which contained pure water. This simple test would allow us to evaluate a number 
of preliminary success parameters qualitatively. Firstly, we wanted to make sure that liquid 
would flow from the 96-well plate to the arena. Secondly, we wanted to ensure that air bubbles 
were not introduced during the switches. Lastly, we wanted to see, in general, how much residual 
dye was left over after the rinse cycle. 
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 For this study, we used a microfluidic device created by our advisor, which is named 
"P2". This device (shown below in Figure 29) has four inlets, one worm loading port, and one 
outflow port. In the figure, “A” denotes the buffer port, “B” denotes the chemical inlet, the 
control inlets are abbreviated “ctrl1” and “ctrl2”, “loading” indicates the worm loading port, and 
“out” refers to the outflow port. 
 
Figure 29: P2 Microfluidic Device 
Usually, the four inlets are used to connect the chemical-containing reservoir (i.e. 96-well 
plate), a buffer reservoir, and two tubes that are attached to a control reservoir via a switch valve. 
The only liquids that ever flow through the arena are the chemical and the buffer. Only one of 
these liquids ever flows through the arena at any given time, and their alternation is dictated by 
whichever control liquid is flowing. For simplicity, we used a P2 device that only had the 
chemical and buffer inlets punched. With this setup, we could not switch between the two 
liquids, as they both flowed through the arena at the same time, but it was very simple to balance 
the flows of the two inlet liquids, which allowed us to determine an appropriate mounting height 
for the buffer reservoir. For the purpose of qualitatively evaluating functionality of our system, 
this two-inlet P2 device was suitable. 
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 Unfortunately, we ran into an obstacle during the first step of this evaluation―when we 
set up the system and began to flow the dye, it did not enter the arena. We deduced that this was 
due to the fact that the accompanying buffer reservoir experienced less resistance than the well 
containing dye. We further realized that this was likely influenced by two factors, the height 
difference of each reservoir (i.e. buffer and well) and the length of each tube connecting the 
reservoirs to the arena. Once we balanced the heights to compensate for the variation, we were 
able to visualize the correct distribution of the dye and clear liquid in the arena. Due to some 
bubble complications, unrelated to the automated switching, we were not able to assess whether 
the act of switching would introduce bubbles. Additionally, because the dye was very faint, we 
were not able to quantify how much residual dye was left after each switch. Due to these 
obstacles, we planned a series of validation experiments that would allow us to qualitatively and 
quantitatively evaluate these parameters. 
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 Chapter 5: Design Verification & Results 
We conducted three main validation tests, including a switching rate study using 
fluorescein, a cross-contamination study also using fluorescein, and a neural screening assay 
with C. elegans, using the attractive odor diacetyl. These experiments were both progressions 
from the initial dye test, since the results from that validation test were not conclusive, nor did 
they provide us with quantitative results. Overall, the purpose of these tests was to validate that 
our initial constraints and objectives were met. 
5.1 Chemical Switching Rate 
We initially tested the duration needed to completely switch from fluorescein to DI-
water. To do this, we established the flow from a fluorescein-containing well, and switched the 
tubing to a DI-water well. We recorded this transition using fluorescence microscopy, and 
quantified the results of this transition using an ImageJ tool that analyzes fluorescent intensity 
levels over time, called “Intensity vs Time plot”. The results from this analysis are shown below, 
in Figure 30. When the fluorescence levels out at the baseline intensity, this signifies a complete 
chemical switch, which occurred after approximately 50 seconds. 
74 
 
  
Figure 30: Chemical switching rate using fluorescein and ImageJ to quantify results 
 
5.2 Cross-Contamination Study 
 
As previously discussed, one of our experimental constraints included having a chemical 
carryover less than 0.01%. We tested this value by using fluorescein and water as substitutes for 
the chemicals that would be used in a traditional chemical screening experiment. The reason we 
used fluorescein and water was because they provided us with a useful platform to assess cross-
contamination between chemicals quantitatively. Fluorescein is a molecule that fluoresces when 
exposed to blue fluorescent light, thus it is very useful as a tracer for imaging. This validation 
test was conducted using two distinct experimental methodologies (i.e. without and with a rinse), 
as shown below in Figure 31 and Figure 32, respectively. For our experiments, we conducted 
method one using wells A1-A12, and method two using wells A1-A6. During the study of 
Method 2, air bubbles entered the microfluidic arena during the latter portion of flow from the 
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 well-plate. For this reason, to maintain consistency for our results, we performed a cross-
contamination analysis of only wells A1-A5 for both methods. 
 
Figure 31: Method 1 for fluorescein cross-contamination, without rinse between switches 
 
Figure 32: Method 2 for fluorescein cross-contamination, with rinse between switches 
 
We used the ImageJ tool previously discussed to evaluate the amount of cross-
contamination present during the switches from each fluorescein containing well to the 
successive water well. The analysis process began by establishing a baseline of fluorescent 
intensity, which was done using well A1, as it contained pure DI-water. The analysis for this 
baseline well is shown below in Figure 33. Two measurements of fluorescent intensity were 
taken for each set of images, one in the experimental area of the microfluidic arena, and another 
in a background region of the PDMS where no liquid was present throughout the experiment. By 
taking two separate measurements, we were able to compare the intensity levels, per frame, 
reducing the noise that may be present due to fluorescein’s sheer intensity affecting the areas that 
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 did not contain the compound (i.e. the background PDMS). To quantify cross-contamination 
between wells, we took measurements of fluorescent intensity from the wells that contained 
fluorescein, and we compared these values to the succeeding water wells that ideally do not 
contain any fluorescein, unless contaminated. 
 
 
Figure 34 below shows the microfluidic arena during flow from a fluorescein 
experimental well (well A2). The fluorescein wells elicited a spike in intensity over time until the 
Figure 33: Image J software that was used to analyze the fluorescent intensity of the DI-water entering 
the microfluidic arena. The yellow box (indicated with red arrow) is the area that is being analyzed. The 
graphs display the change in mean fluorescent intensity over time (slice of image). 
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 stimulus was removed. The background PDMS measurement in the figure below is used to 
quantify how much the fluorescein affected the fluorescent intensity of the “background” or 
surrounding PDMS.  
 
Figure 34: Image J software that was used to analyze the fluorescent intensity of the fluorescein entering 
the microfluidic arena. The yellow box (indicated with red arrow) is the area that is being analyzed. The 
graphs display the change in mean fluorescent intensity over time (slice of image). 
After we obtained the list of 300 fluorescence data points from each experimental well, 
which is equivalent to 30 seconds at 10 frames per second, we were able to quantify the results in 
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 Excel using the template shown below in Figure 35. Each 30 second trial included a 10-second 
pulse of fluorescein, occurring from the 5-15 second marks. By subtracting the background noise 
from the intensity levels of the experimental region during each fluorescein pulse, we were able 
to establish a more reliable set of data for each well. The cross-contamination was calculated by 
analyzing each switch from a fluorescein well to a water well, for example, well A2 to well A3. 
For this analysis, a comparison was made between the experimental liquid and the control buffer, 
which, throughout all of our cross-contamination study, was presumably pure DI-water. For our 
calculations, we used the fluorescent intensity values acquired during the 10-second pulse of 
fluorescein to quantify cross-contamination. The results from this analysis are shown below in 
Table 5. It should be noted that in each of these summaries, the time points are referred to in 
terms of frame number, i.e. the 5-15 second marks are equivalent to frames 50-150. 
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Figure 35: Excel spreadsheet used as a template for our data analysis. The highlighted values were the 
most important for our analysis. 
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Table 5: Results from the chemical cross-contamination from well A1 to A5, experiment 1 with no rinse 
and experiment 2 with a rinse. 
Experiment 1 (no 
rinse) Fluorescent Intensity Cross-contamination (%) 
A1 (water) 0.350553 N/A 
A2 (fluor.) 3358.147 
0.030872 
A3 (water) 1.01267 
A4 (fluor.) 3306.056 
0.02017 
A5 (water) 0.636682 
Average  0.025521 
Experiment 2 (rinse)   
A1 (water) 0.5763 N/A 
A2 (fluor.) 6457.982 
0.007686 
A3 (water) 0.45143 
A4 (fluor.) 6160.797 0.007199 
 A5 (water) 0.505895 
Average  0.007442 
 
The graphs in Figure 36 below display the change of fluorescent intensity per each 
experimental well, from water wells (A1, A3, A5) to fluorescein wells (A2, A3), using each 
methodology. 
 
Figure 36: (A) Experiment 1:  Fluorescent intensity per each well plate with no rinse; (B) Experiment 2:  
Fluorescent intensity per each well plate with one rinse. 
A B 
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 Through these experiments we found that without a rinse cycle the cross-contamination 
was 0.0255%. With the inclusion of a rinse cycle during screening experiments the chemical 
cross-contamination was 0.0074%. 
5.3 C. elegans Automated Chemical Screen 
 Once we completed the tests required to validate that our initial objectives and constraints 
were met, we needed to evaluate our system’s ability to replace the manual method for C. 
elegans chemical screening. To do this, we reproduced an experiment that was previously 
conducted with the manual method, using our automated system, and compared the results 
obtained from each methodology. The experiment, which was originally conducted by Larsch et 
al., involved studying the neural response of a worm strain with fluorescently labeled AWA 
neurons, by means of calcium imaging. This study demonstrated that these neurons respond in an 
attractive manner when the worms are exposed to diacetyl. Furthermore, this study revealed that 
the calcium response to diacetyl occurred with dose dependency; higher concentrations of 
diacetyl elicited larger increases in fluorescent intensity levels. The experiment reported in their 
paper compared a number of different concentrations of diacetyl (i.e. 0.001 μM, 0.01 μM, 0.1 
μM, 1 μM, 10 μM, and 100 μM), each of which was exposed to the worms for a 10-second 
period of time, with 5-seconds of recording before and after exposure, and a 50-second interval 
without exposure or recording between pulses.  
To recreate this dataset, we conducted an automated version, and exposed the worms to 
six different concentrations, 0.1 μM, 1 μM, 10 μM, 100 μM, 1,000 μM, and 10,000 μM each in 
triplicate. These diacetyl concentrations were loaded into wells A1, A3, A5, A7, A9, and A11, 
with intermittent S. basal rinses between those experimental wells. We were able to use all 12 
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 wells for this study, as we resolved the issues with air bubble infiltration that occurred during the 
cross-contamination tests. 
Although we recorded all six concentration responses, including those to 1,000 μM and 
10,000 μM diacetyl, Larsch et al. did not report these two concentration levels, so we omitted 
them in our comparison. To create these concentrations, we performed a serial dilution, 
beginning with stock diacetyl (1 M). To create 10,000 μM diacetyl, we pipetted 30 μL of stock 
diacetyl into 30 mL of S. basal buffer. For each serial dilution, we pipetted 200 μL of the 
previous concentration into 1800 μL of S. basal (e.g. 200 μL of 10,000 μM + 1800 μL S. basal = 
1,000 μM diacetyl). This process was repeated for each dilution down to 0.1 μM diacetyl. The 
worms were exposed to each concentration for a 10-second period of time, with 5-seconds of 
recording prior to and 15-seconds following exposure. Each repetition was separated by a 30-
second period without recording, and each new concentration was separated by 45-seconds. 
Concentrations of diacetyl were sequentially delivered to the worms from low (0.1 μM), 
to high (10,000 μM). The worms’ responses were recorded at 10 frames per second, with a blue 
fluorescent light pulsation rate of 10 ms, which was dictated by the MicroManager system set up 
on an accompanying computer. For evaluation purposes, there were 11 animals that we were able 
to analyze for all concentrations, although the device was originally loaded with 21 worms. 
These animals, along with their tagged AWA neurons, can be seen below in Figure 37. It should 
be noted that, while there are 13 green arrows in the figure, two of these worms were omitted 
because they could not be used for all concentrations. This was due to the fact that, despite these 
animals being immobilized via paralysis, some of the paralysis effects wore off during the 
experiment, causing them to go out of frame or collide with one another. 
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Figure 37: Image of C. elegans' AWA neurons responding to diacetyl, where each animal’s AWA neurons 
are labeled by a green arrow. 
Using previously published worm-tracking algorithms (i.e. ImageJ, MATLAB), the 
fluorescent intensity levels of each worm’s AWA neurons were determined with respect to time. 
These values directly correlate to calcium activity, thus they can be used to measure each worm’s 
neural response. The average neural responses of 11 different worms to each diacetyl 
concentration are shown below in Figure 38. 
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Figure 38: Average dose response of C. elegans' AWA neurons to different concentrations of diacetyl, 
expressed by changes in fluorescent intensity. 
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 Chapter 6: Discussion 
6.1 Our Results and a Comparison to Larsch et al.’s 
Our fluorescein study not only confirmed that we could meet our experimental constraint 
of there being less than 0.01% cross-contamination between chemicals, but it also found a 
method of conducting this chemical screening experiment that optimizes reaching our cross-
contamination constraint, i.e. Method 2 shown above in Figure 32. Therefore, future chemical 
screening studies would benefit greatly from being conducted using the rinse method.  
Our C. elegans experimental results align quite closely with those obtained by the Larsch 
et al. study, which are shown below in Figure 39. The foremost difference between the Larsch et 
al. methodology and ours is that our study was fully unattended by the researcher due to the aid 
of our automated system. The Larsch et al. study utilized the manual method described in 
Section 2.3.1. Additionally, we delivered 10-s pulses of concentrations of diacetyl in triplicate, 
while Larsch et al. delivered 10 pulses of the same duration. Thus, our complete study was 
shorter in duration than that of Larsch et al. 
Another notable difference between the two studies is that we recorded responses to two 
concentrations, i.e. 1,000 μM and 10,000 μM diacetyl, and Larsch et al. did not, so we omitted 
them in our comparison. Additionally, because these concentrations were so high, they caused 
over-saturated responses in the AWA neurons, thus their inclusion would confound our analysis 
of the results in comparison to the Larsch et al. study. 
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Figure 39: Larsch experimental results; mean AWA fluorescence response to systematic variation in odor 
concentration (10 repeated 10-s pulses) of diacetyl, n= 40 animals38 
Since our experimental methodology was very similar to that of the Larsch et al. study, 
and the results obtained from both were also very similar, we can state that our system was able 
to correctly conduct a neural chemical screening study in C. elegans, without the constant 
researcher attention and intervention needed for manual chemical screening. There are, however, 
small discrepancies between our results and the Larsch et al. results, namely the curves for the 
0.1µM and the 100µM concentrations of diacetyl. These small discrepancies can possibly be 
attributed to variation in the worms’ AWA neural responsivities, as well as different sample 
sizes; Larsch et al. studied 40 immobilized animals, while we studied only 11. Additionally, the 
discrepancies could be attributed to the different number of repeat tests per concentration of 
diacetyl. Because C. elegans can adapt to chemicals, increased exposure to a certain chemical 
will result in an overall lower dose response. We only delivered three 10-s pulses of diacetyl per 
concentration, whereas Larsch et al. delivered 10 repeated 10-s pulses to the animals. Thus, the 
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 overall dose responses of the animals in our study are slightly higher than those of the Larsch et 
al. study. 
6.2 Economics 
Our system eliminates the need for purchasing the commercial liquid delivery systems 
discussed above in Section 2.3.2, thus reducing the cost entailing conducting neural chemical 
screening experiments. The total cost for our system, including the Arduino microprocessors, the 
aluminum tracks, the aluminum slides, the mounting rods, the slide potentiometer, the rapid 
prototyped platform, all of the wires, and any other accessories used in the construction of our 
system, amounted to slightly under $300, which is significantly less expensive of any of the 
automated systems described in Section 2.3.2, as they were all priced above $10,000. A side-by-
side comparison of the cost breakdown in relation to other automated systems is shown below in 
Table 6. 
Table 6: Cost comparison of our system with other automated systems 
Part Cost (USD) System Cost (USD)53 
Tracks, slides, and 
mounting rods47,69 167.00 
Biotek Precision 
Microplate Pipetting 
System 
$20,000 
Slide potentiometer 19.95 Biotek MicroFlo $13,000 
Arduino UNO Rev3 
microcontroller board4 21.16 COPAS BIOSORT $300,000 
Arduino Motor Shield 
Rev3 21.16 FACS $18,950 
3D printed platform 23.04   
Total cost 252.31   
 
 
6.3 Environmental Impact 
Our system does not have any significant immediate effect on the environment. 
Nonetheless, improper disposal of screened compounds can result in chemical pollution, but this 
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 does not have any implications related to our system, as the researcher is responsible for cleaning 
the work space and proper disposal of experimental compounds. 
6.4 Societal Influence 
Our system provides a more time-efficient method for neural drug screening studies. If 
one were to study all 1280 pharmacologically active compounds in the University of 
Massachusetts Medical School’s Small Molecule Screening Facility (UMMS SMSF) library, 
with three concentrations per compound, it would take 30.27 8-hour work days total, as 
calculated below in Equation 1 (Parelkar).  
Equation 1: Time needed to screen all 1280 pharmacologically active compounds in the UMMS SMSF 
library 4 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒𝑟𝑟 × 12 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒𝑟𝑟 𝑒𝑒𝑒𝑒𝑐𝑐ℎ × 225 𝑟𝑟 𝑝𝑝𝑒𝑒𝑟𝑟 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒 = 10,800 𝑟𝑟 𝑓𝑓𝑟𝑟𝑟𝑟 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒𝑟𝑟 4 𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑟𝑟𝑒𝑒𝑟𝑟𝑟𝑟𝑒𝑒 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒𝑟𝑟 × 12 𝑟𝑟𝑒𝑒𝑟𝑟𝑟𝑟𝑒𝑒 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒𝑟𝑟 ×  2 𝑟𝑟 𝑝𝑝𝑒𝑒𝑟𝑟 𝑟𝑟𝑒𝑒𝑟𝑟𝑟𝑟𝑒𝑒 = 96 𝑟𝑟 𝑓𝑓𝑟𝑟𝑟𝑟 𝑟𝑟𝑒𝑒𝑟𝑟𝑟𝑟𝑒𝑒𝑟𝑟 10,800 𝑟𝑟 𝑓𝑓𝑟𝑟𝑟𝑟 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒𝑟𝑟 + 96 𝑟𝑟 𝑓𝑓𝑟𝑟𝑟𝑟 𝑟𝑟𝑒𝑒𝑟𝑟𝑟𝑟𝑒𝑒𝑟𝑟 = 10,896 𝑟𝑟 𝑝𝑝𝑒𝑒𝑟𝑟 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒 𝑝𝑝𝑒𝑒𝑒𝑒𝑎𝑎𝑒𝑒 1280 𝑐𝑐𝑟𝑟𝑒𝑒𝑝𝑝𝑟𝑟𝑐𝑐𝑟𝑟𝑐𝑐𝑟𝑟 × 3 𝑐𝑐𝑟𝑟𝑟𝑟𝑐𝑐.𝑝𝑝𝑒𝑒𝑟𝑟 𝑐𝑐𝑟𝑟𝑒𝑒𝑝𝑝𝑟𝑟𝑐𝑐𝑟𝑟𝑐𝑐 = 3840 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒𝑟𝑟  3840 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒𝑟𝑟48 𝑒𝑒𝑎𝑎𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑒𝑎𝑎𝑒𝑒𝑒𝑒 𝑐𝑐ℎ𝑒𝑒𝑒𝑒𝑒𝑒𝑐𝑐𝑒𝑒𝑒𝑒 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒𝑟𝑟 𝑝𝑝𝑒𝑒𝑟𝑟 𝑝𝑝𝑒𝑒𝑒𝑒𝑎𝑎𝑒𝑒 =  80 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒 𝑝𝑝𝑒𝑒𝑒𝑒𝑎𝑎𝑒𝑒𝑟𝑟 80 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒 𝑝𝑝𝑒𝑒𝑒𝑒𝑎𝑎𝑒𝑒𝑟𝑟 × 10,896 𝑟𝑟 𝑝𝑝𝑒𝑒𝑟𝑟 𝑟𝑟𝑒𝑒𝑒𝑒𝑒𝑒 𝑝𝑝𝑒𝑒𝑒𝑒𝑎𝑎𝑒𝑒 = 871,680 𝑟𝑟 = 14,528 min =242 ℎ𝑟𝑟𝑟𝑟  𝑎𝑎𝑟𝑟 𝑎𝑎𝑒𝑒𝑟𝑟𝑎𝑎 𝑒𝑒𝑒𝑒𝑒𝑒 𝑐𝑐𝑟𝑟𝑒𝑒𝑝𝑝𝑟𝑟𝑐𝑐𝑟𝑟𝑐𝑐𝑟𝑟  
  
The times used for individual chemical wells and rinse wells (i.e., 225 s and 2 s 
respectively), can be altered according to the specific needs for each individual study. Generally, 
the total duration of a screening study should not exceed several hours, since C. elegans 
responses begin to fluctuate after a certain amount of exposure to neural activity-altering 
compounds. Thus, as long as the time to screen chemicals using one 96-well plate does not 
exceed several hours, the individual times for each well can vary. Using our system eliminates 
the need for constant attention and intervention from the researcher, thus resulting in 242 hours, 
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 as calculated above, that can be dedicated to other tasks, since our system is hands-off and 
automated. Therefore, our system would save a researcher approximately 30.27 8-hour 
workdays. 
6.5 Political Ramifications 
Although our system does not have a direct influence on the culture of other countries, it 
can increase the pace of worldwide neural research, making access to in vivo and clinical trials 
much easier, thus increasing the chances of finding adequate drug treatments for 
neuropsychiatric disorders. Building off of these political ramifications of our system, as 
research in this particular field becomes more prevalent, we feel that mental disorders will 
become less of a taboo subject in the world, which in turn will fuel neural research even further, 
thus creating a cycle of acceptance, funding, and research. 
6.6 Ethical Concern 
Since our system is primarily meant for research using a microscopic, invertebrate animal 
model, i.e. C. elegans, there are very few ethical considerations that must be taken into account.  
Animal care protocols are used to outline the considerations that must be taken when conducting 
research using vertebrate models (e.g. mice), but they do not apply to C. elegans. There exists a 
debate over whether or not invertebrates, as a whole, experience pain in the same way 
vertebrates do. Given that C. elegans are invertebrate, low-order organisms, they do not warrant 
standard animal care practices that are required for higher-order, vertebrate species. While 
animal testing is a necessary transition between in vitro studies and human trials, the use of C. 
elegans is far less unethical than other, more complex animal models. 
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 6.7 Health and Safety Issues 
Our system has very obvious and immediate implications in the health and quality of life 
of those who suffer from neuropsychiatric disorders with no proper treatment options. It greatly 
increases the possibility of finding drug treatments for mental disorders (such as autism, 
schizophrenia, depression, and many others), while increasing the potential of minimizing 
detrimental side effects associated with drug treatments. 
As for safety issues in regards to the researcher/user, our system poses very little 
immediate threat. The slide potentiometer moves very quickly, but the tubing is not sharp or stiff 
enough to cause personal harm. Contrarily, there is a small risk of a chemical spill occurring, 
which could potentially damage the objective microscope beneath the microfluidic arena, since it 
is an electronic device, unprotected from liquid damage. However, this risk is still present during 
manual chemical screening experiments, although slightly higher with our system, since there is 
no way for the system to self-correct errors. 
6.8 Manufacturability 
Our system is very straightforward to reproduce, since all of our materials are open-
source. In order to facilitate reproduction of our system, we have included all our schematics and 
code involved with the creation of our system. Additionally, our system is comparatively more 
straightforward than other high-throughput screening methods, since highly comparable systems 
are only accessible via a facility-based approach. A total of 105 laboratory facilities have 
experimental setups in which microfluidic C. elegans screening experiments can be conducted, 
but the researcher would have to travel to one of the facilities to be able to use it, whereas our 
system can be assembled and used in any laboratory at a small cost.1 
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 6.9 Sustainability 
Our system does not have any immediate effect on sustainability, besides electricity 
usage and the manufacturing of aluminum and rapid prototyped parts. The effects of these 
factors on the environment as a whole is minimal, thus the production of our system has no 
significant impact on ecology. 
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 Chapter 7: Final Design and Validation 
7.1 Chemical Screening in C. elegans 
C. elegans are an ideal candidate for chemical screening because of their complete 
connectome and their genetic conservation to humans, which allows them to model human 
diseases that can then be tested. These nematodes are ideal for high-throughput testing because 
they are inexpensive, easily imaged due to being transparent, and are small, allowing many 
animals to be monitored at once. There currently exists a way to monitor neural responses of C. 
elegans to chemical stimuli and it is high-throughput in that many animals can be monitored at 
once and that many chemicals can be administered, but it requires the experimenter’s presence, 
which is limiting. Also, timing by an individual experimenter would not be consistent due to 
human error, so there is a need to automate the process. 
7.2 Creating an Automated System for Chemical Screening 
The team's goal was to create an automated system that would be able to draw chemicals 
from a 96-well plate and deliver them to a microfluidic arena where the response of C. elegans 
would be able to be monitored. Using the imaging system already established, the team only 
needed to be concerned with creating a system that would be able to process input commands 
that dictate the timing and actions of the system. By creating a system that is able to automate the 
chemical screening process, the experimenter would save time and the results would be more 
accurate, due to each stimulus being administered consistently. 
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 7.3 Engineering Design 
7.3.1 Overview 
The team was given a system with a standard wheel carriage plate that traveled in two 
dimensions along an aluminum v-rail system. The system was programmed to move in distances 
that correlated to the length and width of each well in a 96-well plate, so that a vertical 
component would be able to draw from a specific well when the carriage plate moved. To ensure 
the proper flow of chemicals, the 96-well plate could not be placed on top of the carriage plate, 
so as to minimize the height difference of the 96-well plate and the microfluidic arena. The 
system also had to switch chemicals within 0.5 seconds, which would dictate the speed and range 
of the components of the system. The team decided to use a system that incorporated a fixed z-
axis component, which would draw the chemicals out of the plate, and a movable xy-plane that 
would facilitate switching between wells.  
7.3.2 96-Well Plate Platform 
In order for the system to function as desired, the chemical containing 96-well plate 
needed to be suspended from the x- and y- moving carriage plate so that it was as close to being 
as low as the microfluidic arena as possible, but while still fitting within the spatial confines of 
the system already created. Two iterations of a 96-well plate platform holder were constructed in 
SolidWorks and then 3-D printed. The first iteration showed that the 96-well plate fit within the 
platform, but was too weak to support the plate without major deformation. The platform was 
then made thicker with supporting walls to minimize deformation and succeeded at holding the 
96-well plate and was firmly attached to the carriage plate. 
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 7.3.3 Slide Potentiometer for Z-Axis Movement 
Once the 96-well plate was able to move in the x- and y- direction, a method for moving 
the tubing in the z-axis to draw chemicals from the wells and deliver them to the microfluidic 
arena was needed. A slide potentiometer was chosen due to its speed and low cost. The slide pot 
needed to be programmed using an Arduino; this was done so that it moved enough for the 
attached tubing to reach the bottom of each well, and then also to raise enough so that the tubing 
would not drag along other wells when the plate moved in the x- and y- direction. Hypodermic 
tubing was then secured to the slide pot so that the rigid plastic tubing would be secured to it 
simply by sliding it in, allowing for easy switching of tubing. 
7.4 Experimental Methods 
7.4.1 Overview 
Once the system’s ability to move in the x-, y-, and z- directions, to elicit chemical flow, 
was confirmed, the system needed validation testing to ensure that the efficacy of the system was 
on par with the manual method. Cross-contamination rate from one well to the next was 
investigated by using fluorescein. Once the cross-contamination rate was at the accepted amount 
of less than 0.01%, the system's viability was confirmed with live animal testing that could be 
compared to existing data. 
7.4.2 Fluorescein Cross-contamination Testing 
Cross-contamination is a serious concern when screening drugs; without the ability to 
distinguish individual drugs from one another, the response data will be corrupted. Therefore, we 
had the goal of achieving a chemical cross-contamination of less than 0.01% between drug 
switches. To quantify the cross-contamination of the system, the team used fluorescein to 
measure the cross-contamination between trials. Two methods were used to test cross-
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 contamination rate. In one method, fluorescein was sequentially tested with DI-water, and the 
amount of fluorescence that carried over from the previous fluorescein well into the successive 
DI-water well, after subtracting the baseline of fluorescence of the PDMS, indicated the cross- 
contamination. A second method, which included a DI-water rinse after each chemical switch, 
was then used to see if the resulting cross-contamination would be reduced due to a rinse. 
7.4.3 Live Animal Testing 
To confirm the efficacy of our system further, we conducted live animal testing using C. 
elegans. We replicated a study previously conducted by Larsch et al., where the AWA neurons 
respond to diacetyl exposure. The team’s automated dose response was conducted at six different 
concentrations of diacetyl (0.1 µM, 1 µM, 10 µM, 100 µM, 1,000 µM, and 10,000 µM) with 
three pulses each on 11 animals, and the animals’ neural responses were analyzed. The highest 
two concentrations (i.e. 1,000 µM and 10,000 µM) were omitted from our comparison to 
previous studies, due in part to the lack of existing data for these particular concentrations. After 
speaking with our advisor, we deduced that the differences in the results for these two 
concentration levels could be due to saturation of neural responses, as well as adaptation of the 
animals to the chemical stimulus. 
7.4.4 Experimental Setup 
We conducted these experiments in a similar fashion to that described in Section 4.6.4, 
with the exception that all four of the device’s inlets were punched, allowing us to deliver 
chemical pulses. 
96 
 
 7.5 Results 
From the fluorescein study, we found that the inclusion of a rinse cycle between chemical 
switches effected a cross-contamination between chemicals that was within our initial cross-
contamination constraint of 0.01%. The cross-contamination rate with no rinse was found to be 
0.025% while including a rinse reduced the cross-contamination to 0.0074%, meeting our 
constraint of being lower than 0.01%. A complete chemical switch between well A1 to well A2 
occurred within approximately 50 seconds, which was also within our switching speed constraint 
of 60 seconds. 
Building off of our previous successful results, we conducted animal studies evaluating 
the AWA neural response of C. elegans when exposed to different concentrations of diacetyl. 
Our system was effective in eliciting the expected C. elegans neural responses, after we 
replicated a portion of the previously mentioned Larsch et al. Study. Our results, represented in 
Figure 38, show the fluorescent response of the nematodes' AWA neurons increasing with higher 
concentrations of diacetyl. This matches the results found by Larsch et al. with minimal 
differences. Lastly, our entire project had a budget of $500 to create the automated system. We 
only ended up spending $252.31 for everything we used, so we managed our budget very well by 
choosing good components at an ideal price. It is worth noting that the entire set up could not be 
replicated for this amount, due to the cost of the camera, but the automated system component 
that we constructed was able to fit within all of our restrictions. 
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 Chapter 8: Conclusions and Recommendations 
As discussed in Chapter 6, the potential impact of our system is immense. Because our 
system is able to accurately replicate a neural chemical screening experiment conducted 
manually using C. elegans, the effects of the Larsch et al. study are intertwined with the effects 
of the creation of our system. Additionally, our system has the added effect of increasing the 
throughput of screening experiments that were already high-throughput to begin with. The 
implications of neural screening experiments in general, associated with the increased throughput 
of such experiments, essentially entails that our system can indirectly improve the quality of life 
of millions of people worldwide who suffer from neuropsychiatric illness, at a faster pace than 
current research methods. Moreover, the researcher can spend the 242 hours it takes to test all of 
the pharmacologically active compounds available completing other research or tasks, thus 
increasing the individual researcher’s overall productivity, which in turn can increase the overall 
productivity of all researchers worldwide. 
Before going ahead and testing all 1,280 chemicals, we recommend testing the system 
even more to see that it is reliable and consistent. While we tested the flow rate and the cross-
contamination for the switching of chemicals, there was more that could have been done to make 
sure the system would be able to handle so hundreds of hours of work. The maximum number of 
wells we tested using the automated system was 12, which was performed in both the cross-
contamination and the C. elegans automated dose response studies. The system did not run into 
any problems when it came to this, but to ensure ideal performance, we recommend running 
several tests where all 96 wells of the plate are accessed. This should be done several times, 
timing each trial to make sure the timing is consistent as well. Another reliability factor we could 
test is the depth the tubing travels in each well. This could be done by filling all of the wells with 
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 a certain amount of liquid and then timing each one until the well is empty. If the wells do not 
drain at the same rate, then the thresholds for dipping into the wells would need to be changed. 
One more reliability aspect that can be challenged, which would be lengthy, is to test how many 
Press N' Seal wrap punctures the sharp tubing can endure before becoming dull. This could be 
done by just having the system rapidly puncture different well covers until the tubing fails to 
puncture on the first try. This would give an estimate as to how often the tubing needs to be cut 
to ensure proper function. 
Although we were able to reach the goals we had for our system, there are several 
improvements that can be made to our system, thus strengthening the positive impact it has even 
further. One potential improvement is crafting the plate holder platform out of aluminum. This is 
desirable because the durability of aluminum is much greater than that of 3-D printed plastic and 
is light enough to not impact how the system functions. Another potential improvement is 
creating a remote video monitoring system that the experimenter could check from their office, 
home, or even on their smartphone. By allowing for viewing of the system remotely, the 
experimenter can ensure that the experiment is running properly and safely, as any unattended 
use of chemicals should be handled carefully. A major potential improvement to our system 
would be the ability for it to self-diagnose and solve errors that have occurred. By implementing 
measures to ensure consistent flow rate and proper imaging, time and materials could be saved so 
that no trial is wasted due to an error occurring. One last improvement that could be made is to 
make the overall system safer. While the system is currently only available to trained personnel 
that have specifically been given access, there is a need to ensure that chemical spills do not 
interact with electronics or humans in the area. A constantly running vacuum system where 
potential leaks may occur would ensure that chemicals are not displaced in an undesired area. 
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 Additionally, some kind of protective shielding could be useful to limit the exposure the 
chemicals have with humans if there were to be a spill. 
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 Appendix D 
 
The following schematic displays the dimensions of the 96-well plate platform that we used in 
our automated system. 
 
 
Units: mm 
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